"<?xml version=\"1.0\" encoding=\"utf-8\"?><rss version=\"2.0\" xmlns:atom=\"http://www.w3.org/2005/Atom\" xmlns:content=\"http://purl.org/rss/1.0/modules/content/\" xmlns:dc=\"http://purl.org/dc/elements/1.1/\"><channel><title>Radiology</title><link>https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=0401260%20%5BNLMID%5D&amp;utm_medium=rss&amp;utm_source=no_user_agent&amp;utm_campaign=journals&amp;utm_content=0401260&amp;ff=20250409092454&amp;fc=None&amp;v=2.18.0.post9+e462414</link><description>Radiology: Latest results from PubMed</description><language>en</language><pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate><lastBuildDate>Wed, 09 Apr 2025 13:24:57 +0000</lastBuildDate><generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator><docs>http://www.rssboard.org/rss-specification</docs><ttl>120</ttl><atom:link href=\"https://pubmed.ncbi.nlm.nih.gov/?sort=date&amp;term=0401260%20%5BNLMID%5D&amp;utm_medium=rss&amp;utm_source=no_user_agent&amp;utm_campaign=journals&amp;utm_content=0401260&amp;ff=20250409092454&amp;fc=None&amp;v=2.18.0.post9+e462414\" rel=\"self\"></atom:link><item><title>Angiofibroma of Soft Tissue in the Liver</title><link>https://pubmed.ncbi.nlm.nih.gov/40197100/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40197100</guid><pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e242524. doi: 10.1148/radiol.242524.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40197100/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40197100</a> | DOI:<a href=https://doi.org/10.1148/radiol.242524>10.1148/radiol.242524</a></p></div>]]></content:encoded><dc:creator>Xi Jia</dc:creator><dc:creator>Mengsu Zeng</dc:creator><dc:date>2025-04-08</dc:date><dc:identifier>pmid:40197100</dc:identifier><dc:identifier>doi:10.1148/radiol.242524</dc:identifier><dc:source>Radiology</dc:source><dc:title>Angiofibroma of Soft Tissue in the Liver</dc:title></item><item><title>CT Lymph Node Patterns in MSI-High Colon Cancer: A Potential Solution to a Mystery</title><link>https://pubmed.ncbi.nlm.nih.gov/40197099/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40197099</guid><pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e250556. doi: 10.1148/radiol.250556.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40197099/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40197099</a> | DOI:<a href=https://doi.org/10.1148/radiol.250556>10.1148/radiol.250556</a></p></div>]]></content:encoded><dc:creator>Naama Lev-Cohain</dc:creator><dc:creator>Jacob Sosna</dc:creator><dc:date>2025-04-08</dc:date><dc:identifier>pmid:40197099</dc:identifier><dc:identifier>doi:10.1148/radiol.250556</dc:identifier><dc:source>Radiology</dc:source><dc:title>CT Lymph Node Patterns in MSI-High Colon Cancer: A Potential Solution to a Mystery</dc:title></item><item><title>Deep Learning Applications in Imaging of Acute Ischemic Stroke: A Systematic Review and Narrative Summary</title><link>https://pubmed.ncbi.nlm.nih.gov/40197098/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background Acute ischemic stroke (AIS) is a major cause of morbidity and mortality, requiring swift and precise clinical decisions based on neuroimaging. Recent advances in deep learning-based computer vision and language artificial intelligence (AI) models have demonstrated transformative performance for several stroke-related applications. Purpose To evaluate deep learning applications for imaging in AIS in adult patients, providing a comprehensive overview of the current state of the...]]></description><guid isPermaLink=\"false\">pubmed:40197098</guid><pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e240775. doi: 10.1148/radiol.240775.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background Acute ischemic stroke (AIS) is a major cause of morbidity and mortality, requiring swift and precise clinical decisions based on neuroimaging. Recent advances in deep learning-based computer vision and language artificial intelligence (AI) models have demonstrated transformative performance for several stroke-related applications. Purpose To evaluate deep learning applications for imaging in AIS in adult patients, providing a comprehensive overview of the current state of the technology and identifying opportunities for advancement. Materials and Methods A systematic literature review was conducted following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. A comprehensive search of four databases from January 2016 to January 2024 was performed, targeting deep learning applications for imaging of AIS, including automated detection of large vessel occlusion and measurement of Alberta Stroke Program Early CT Score. Articles were selected based on predefined inclusion and exclusion criteria, focusing on convolutional neural networks and transformers. The top-represented areas were addressed, and the relevant information was extracted and summarized. Results Of 380 studies included, 171 (45.0%) focused on stroke lesion segmentation, 129 (33.9%) on classification and triage, 31 (8.2%) on outcome prediction, 15 (3.9%) on generative AI and large language models, and 11 (2.9%) on rapid or low-dose imaging specific to stroke applications. Detailed data extraction was performed for 68 studies. Public AIS datasets are also highlighted, for researchers developing AI models for stroke imaging. Conclusion Deep learning applications have permeated AIS imaging, particularly for stroke lesion segmentation. However, challenges remain, including the need for standardized protocols and test sets, larger public datasets, and performance validation in real-world settings. © RSNA, 2025 <i>Supplemental material is available for this article.</i></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40197098/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40197098</a> | DOI:<a href=https://doi.org/10.1148/radiol.240775>10.1148/radiol.240775</a></p></div>]]></content:encoded><dc:creator>Bin Jiang</dc:creator><dc:creator>Nancy Pham</dc:creator><dc:creator>Eric K van Staalduinen</dc:creator><dc:creator>Yongkai Liu</dc:creator><dc:creator>Sanaz Nazari-Farsani</dc:creator><dc:creator>Amirhossein Sanaat</dc:creator><dc:creator>Henk van Voorst</dc:creator><dc:creator>Ates Fettahoglu</dc:creator><dc:creator>Donghoon Kim</dc:creator><dc:creator>Jiahong Ouyang</dc:creator><dc:creator>Ashwin Kumar</dc:creator><dc:creator>Aditya Srivatsan</dc:creator><dc:creator>Ramy Hussein</dc:creator><dc:creator>Maarten G Lansberg</dc:creator><dc:creator>Fernando Boada</dc:creator><dc:creator>Greg Zaharchuk</dc:creator><dc:date>2025-04-08</dc:date><dc:identifier>pmid:40197098</dc:identifier><dc:identifier>doi:10.1148/radiol.240775</dc:identifier><dc:source>Radiology</dc:source><dc:title>Deep Learning Applications in Imaging of Acute Ischemic Stroke: A Systematic Review and Narrative Summary</dc:title></item><item><title>Breast Cancer Detection with Standalone AI versus Radiologist Interpretation of Unilateral Surveillance Mammography after Mastectomy</title><link>https://pubmed.ncbi.nlm.nih.gov/40197097/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background Limited data are available regarding the accuracy of artificial intelligence (AI) algorithms trained on bilateral mammograms for second breast cancer surveillance in patients with a personal history of breast cancer treated with unilateral mastectomy. Purpose To compare the performance of standalone AI for second breast cancer surveillance on unilateral mammograms with that of radiologists reading mammograms without AI assistance. Materials and Methods In this retrospective...]]></description><guid isPermaLink=\"false\">pubmed:40197097</guid><pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e242955. doi: 10.1148/radiol.242955.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background Limited data are available regarding the accuracy of artificial intelligence (AI) algorithms trained on bilateral mammograms for second breast cancer surveillance in patients with a personal history of breast cancer treated with unilateral mastectomy. Purpose To compare the performance of standalone AI for second breast cancer surveillance on unilateral mammograms with that of radiologists reading mammograms without AI assistance. Materials and Methods In this retrospective institutional database study, patients who were diagnosed with breast cancer between January 2001 and December 2018 and underwent postmastectomy surveillance mammography from January 2011 to March 2023 were included. Radiologists' mammogram interpretations without AI assistance were collected from these records and compared with AI interpretations of the same mammograms. The reference standards were histologic examination and 1-year follow-up data. The cancer detection rate per 1000 screening examinations, sensitivity, and specificity of standalone AI and the radiologists' interpretations without AI were compared using the McNemar test. Results Among the 4184 asymptomatic female patients (mean age, 52 years), 111 (2.7%) had contralateral second breast cancer. The cancer detection rate (17.4 per 1000 examinations [73 of 4184]; 95% CI: 13.7, 21.9) and sensitivity (65.8% [73 of 111]; 95% CI: 56.2, 74.5) were greater for standalone AI than for radiologists (14.6 per 1000 examinations [61 of 4184]; 95% CI: 11.2, 18.7; <i>P</i> = .01; 55.0% [61 of 111]; 95% CI: 45.2, 64.4; <i>P</i> = .01). The specificity was lower for standalone AI than for radiologists (91.5% [3725 of 4073]; 95% CI: 90.6, 92.3 vs 98.1% [3996 of 4073]; 95% CI: 97.6, 98.5; <i>P</i> &lt; .001). AI detected 16 of 50 (32%) cancers missed by radiologists; however, 34 of 111 (30.6%) breast cancers were missed by both radiologists and AI. Conclusion Standalone AI for surveillance mammography showed higher sensitivity with lower specificity for contralateral breast cancer detection in patients treated with unilateral mastectomy than radiologists without AI assistance. © RSNA, 2025 <i>Supplemental material is available for this article.</i> See also the editorial by Philpotts in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40197097/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40197097</a> | DOI:<a href=https://doi.org/10.1148/radiol.242955>10.1148/radiol.242955</a></p></div>]]></content:encoded><dc:creator>Su Min Ha</dc:creator><dc:creator>Janie M Lee</dc:creator><dc:creator>Myoung-Jin Jang</dc:creator><dc:creator>Hong-Kyu Kim</dc:creator><dc:creator>Jung Min Chang</dc:creator><dc:date>2025-04-08</dc:date><dc:identifier>pmid:40197097</dc:identifier><dc:identifier>doi:10.1148/radiol.242955</dc:identifier><dc:source>Radiology</dc:source><dc:title>Breast Cancer Detection with Standalone AI versus Radiologist Interpretation of Unilateral Surveillance Mammography after Mastectomy</dc:title></item><item><title>Parallel Detection of Multicontrast MRI and Deuterium Metabolic Imaging for Time-efficient Characterization of Neurologic Diseases</title><link>https://pubmed.ncbi.nlm.nih.gov/40197096/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background Deuterium metabolic imaging (DMI) is a novel, MRI-based method to map metabolism noninvasively in vivo and has potential to augment existing clinical MRI with unique metabolic information. However, adding DMI scans to a standard, clinical MRI protocol is challenging due to the relatively long scan time of DMI that can result in decreased patient compliance and increased scanning costs. Purpose To design and evaluate a parallel acquisition strategy, based on the large frequency...]]></description><guid isPermaLink=\"false\">pubmed:40197096</guid><pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e241597. doi: 10.1148/radiol.241597.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background Deuterium metabolic imaging (DMI) is a novel, MRI-based method to map metabolism noninvasively in vivo and has potential to augment existing clinical MRI with unique metabolic information. However, adding DMI scans to a standard, clinical MRI protocol is challenging due to the relatively long scan time of DMI that can result in decreased patient compliance and increased scanning costs. Purpose To design and evaluate a parallel acquisition strategy, based on the large frequency difference between hydrogen proton (<sup>1</sup>H) and deuterium (<sup>2</sup>H) MRI signals, to obtain metabolic DMI data during a comprehensive, multicontrast (fluid-attenuated inversion recovery [FLAIR] and T1-, T2-, and susceptibility-weighted) MRI protocol without adding scanning time. Materials and Methods A parallel MRI DMI protocol based on four essential MRI types-FLAIR, and T1-, T2-, and susceptibility-weighted MRI-was interwoven with three-dimensional DMI by executing <sup>2</sup>H acquisition blocks during the contrast-generating delays intrinsic to MRI. Results Phantom and in vivo human brain data show that MRI scan quality, DMI sensitivity, and information content are preserved in the parallel MRI DMI acquisition method. DMI data acquired in parallel with MRI in a patient with an astrocytoma show unique metabolic image contrast that complements the multicontrast MRI examinations. Conclusion Parallel MRI scan acquisition technology was a practical solution to obtain both high-quality anatomic and metabolic scans without prolonging the scanning duration compared with an MRI-only protocol; the method had high flexibility to upgrade traditional MRI protocols with DMI and will be key for many clinical sites to gain access to DMI and drive its further development and validation by use in larger, diverse patient populations. © RSNA, 2025 <i>Supplemental material is available for this article</i>. See also the article by Bøgh et al in this issue. See also the editorial by Port in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40197096/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40197096</a> | DOI:<a href=https://doi.org/10.1148/radiol.241597>10.1148/radiol.241597</a></p></div>]]></content:encoded><dc:creator>Yanning Liu</dc:creator><dc:creator>Henk M De Feyter</dc:creator><dc:creator>Zachary A Corbin</dc:creator><dc:creator>Robert K Fulbright</dc:creator><dc:creator>Scott McIntyre</dc:creator><dc:creator>Terence W Nixon</dc:creator><dc:creator>Robin A de Graaf</dc:creator><dc:date>2025-04-08</dc:date><dc:identifier>pmid:40197096</dc:identifier><dc:identifier>doi:10.1148/radiol.241597</dc:identifier><dc:source>Radiology</dc:source><dc:title>Parallel Detection of Multicontrast MRI and Deuterium Metabolic Imaging for Time-efficient Characterization of Neurologic Diseases</dc:title></item><item><title>The Importance of Imaging Metabolism: A Glimpse into the Future</title><link>https://pubmed.ncbi.nlm.nih.gov/40197095/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40197095</guid><pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e250575. doi: 10.1148/radiol.250575.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40197095/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40197095</a> | DOI:<a href=https://doi.org/10.1148/radiol.250575>10.1148/radiol.250575</a></p></div>]]></content:encoded><dc:creator>John D Port</dc:creator><dc:date>2025-04-08</dc:date><dc:identifier>pmid:40197095</dc:identifier><dc:identifier>doi:10.1148/radiol.250575</dc:identifier><dc:source>Radiology</dc:source><dc:title>The Importance of Imaging Metabolism: A Glimpse into the Future</dc:title></item><item><title>Evaluating Whether Standalone AI Really Stands Up</title><link>https://pubmed.ncbi.nlm.nih.gov/40197094/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40197094</guid><pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e250364. doi: 10.1148/radiol.250364.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40197094/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40197094</a> | DOI:<a href=https://doi.org/10.1148/radiol.250364>10.1148/radiol.250364</a></p></div>]]></content:encoded><dc:creator>Liane E Philpotts</dc:creator><dc:date>2025-04-08</dc:date><dc:identifier>pmid:40197094</dc:identifier><dc:identifier>doi:10.1148/radiol.250364</dc:identifier><dc:source>Radiology</dc:source><dc:title>Evaluating Whether Standalone AI Really Stands Up</dc:title></item><item><title>Predicting Regional Lymph Node Metastases at CT in Microsatellite Instability-High Colon Cancer</title><link>https://pubmed.ncbi.nlm.nih.gov/40197093/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background Early identification of lymph node metastasis is crucial for microsatellite instability-high (MSI-H) colon cancer caused by deficient mismatch repair, but accuracy of CT is poor. Purpose To determine whether CT-detected lymph node distribution patterns can improve lymph node evaluation in MSI-H colon cancer. Materials and Methods This two-center retrospective study included patients with MSI-H colon cancer who underwent pretreatment CT and radical surgery (development set, December...]]></description><guid isPermaLink=\"false\">pubmed:40197093</guid><pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e242122. doi: 10.1148/radiol.242122.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background Early identification of lymph node metastasis is crucial for microsatellite instability-high (MSI-H) colon cancer caused by deficient mismatch repair, but accuracy of CT is poor. Purpose To determine whether CT-detected lymph node distribution patterns can improve lymph node evaluation in MSI-H colon cancer. Materials and Methods This two-center retrospective study included patients with MSI-H colon cancer who underwent pretreatment CT and radical surgery (development set, December 2017-December 2022; test set, January 2016-January 2024). Lymph node characteristics associated with pathologic lymph node metastasis (pN+), including clinical lymph node stage (cN) and distribution patterns (vascular distribution, jammed cluster, and partial fusion), were selected (logistic regression and Kendall tau-b correlation) to create a distribution-based clinical lymph node stage (dcN) in the development set. Diagnostic performance was verified in the test set. Interobserver agreement was assessed by using Fleiss κ. Clinical value of dcN was assessed using univariable logistic analysis among patients in the treatment set receiving neoadjuvant immunotherapy (August 2017-February 2024). Results The study included 368 patients (median age, 60 years [IQR, 50-70 years]; 211 male): 230 from the development set (median age, 59 years [IQR, 49-70 years]), 86 from the test set (median age, 66 years [IQR, 55-79 years]), and 52 from the treatment set (median age, 54 years [IQR, 42-65 years]). Only jammed cluster and partial fusion were associated with higher odds of pN+ (odds ratio, 78.9 and 21.5, respectively; both <i>P</i> &lt; .001). dcN outperformed cN in the test set (accuracy, 90% [78 of 87] vs 46% [40 of 87]; <i>P</i> &lt; .001; specificity, 97% [55 of 57] vs 26% [15 of 57]; <i>P</i> &lt; .001). Interobserver agreement was moderate for dcN (κ = 0.67) and poor for cN (κ = 0.48). dcN was associated with a complete response after neoadjuvant immunotherapy (odds ratio, 0.05; <i>P</i> &lt; .001). Conclusion dcN showed high performance for identifying regional lymph node metastases and helped predict complete response after neoadjuvant immunotherapy in MSI-H colon cancer using a surgical reference standard. © RSNA, 2025 <i>Supplemental material is available for this article.</i> See also the editorial by Lev-Cohain and Sosna in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40197093/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40197093</a> | DOI:<a href=https://doi.org/10.1148/radiol.242122>10.1148/radiol.242122</a></p></div>]]></content:encoded><dc:creator>Zhen Guan</dc:creator><dc:creator>Zheng-Hang Wang</dc:creator><dc:creator>Xiao-Yan Zhang</dc:creator><dc:creator>Shuo Yan</dc:creator><dc:creator>Ting Xu</dc:creator><dc:creator>Jian Li</dc:creator><dc:creator>Lin Shen</dc:creator><dc:creator>Ying-Shi Sun</dc:creator><dc:date>2025-04-08</dc:date><dc:identifier>pmid:40197093</dc:identifier><dc:identifier>doi:10.1148/radiol.242122</dc:identifier><dc:source>Radiology</dc:source><dc:title>Predicting Regional Lymph Node Metastases at CT in Microsatellite Instability-High Colon Cancer</dc:title></item><item><title>Comparison of Deuterium Metabolic Imaging with FDG PET in Alzheimer Disease</title><link>https://pubmed.ncbi.nlm.nih.gov/40197092/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background The approval of amyloid-targeting therapies has made it increasingly important to differentiate Alzheimer disease (AD) from other causes of dementia. Dysfunctional glucose metabolism is a recognized pathophysiological element in AD that may be visualized with spectroscopic MRI of deuterated glucose and its metabolites, also known as deuterium metabolic imaging (DMI). Purpose To explore the potential of DMI as a diagnostic tool for AD. Materials and Methods In this prospective...]]></description><guid isPermaLink=\"false\">pubmed:40197092</guid><pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e241808. doi: 10.1148/radiol.241808.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background The approval of amyloid-targeting therapies has made it increasingly important to differentiate Alzheimer disease (AD) from other causes of dementia. Dysfunctional glucose metabolism is a recognized pathophysiological element in AD that may be visualized with spectroscopic MRI of deuterated glucose and its metabolites, also known as deuterium metabolic imaging (DMI). Purpose To explore the potential of DMI as a diagnostic tool for AD. Materials and Methods In this prospective cross-sectional study, participants with newly diagnosed AD and age-matched controls were recruited from April to October 2023. DMI was performed with a 3-T system equipped with a proton/deuterium head coil following oral consumption of 75 g of deuterated glucose. Clinical fluorodeoxyglucose (FDG) PET data were acquired from patient records for comparison. The predefined primary outcome, the ratio between lactate and glutamine plus glutamate (Glx) at DMI, was analyzed using age-corrected linear mixed-effect models. Results Ten participants with AD (mean age, 72 years ± 6 [SD]; six women) and five age-matched healthy controls (mean age, 68 years ± 7; four men) were included. The primary analysis revealed no evidence of a difference in the ratio of lactate to Glx between participants with AD and controls (<i>P</i> = .24 across all regions of interest). Exploratory analyses revealed that participants with AD had reduced signals for medial temporal lactate (0.7 ± 0.2 vs 0.5 ± 0.1, <i>P</i> = .04) and Glx (0.5 ± 0.03 vs 0.48 ± 0.05, <i>P</i> = .03) compared with controls. Finally, a strong correlation (<i>r</i> = 0.73) was observed between DMI and FDG PET. Conclusion This study did not find evidence to support a shift from oxidative to anaerobic metabolism in AD. Exploratory analyses revealed a decrease in glucose metabolism in the medial temporal lobe. In extension hereof, a similar distribution of low DMI metabolism and decreased FDG PET glucose uptake was observed. © RSNA, 2025 <i>Supplemental material is available for this article.</i> See also the article by Liu et al in this issue. See also the editorial by Port in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40197092/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40197092</a> | DOI:<a href=https://doi.org/10.1148/radiol.241808>10.1148/radiol.241808</a></p></div>]]></content:encoded><dc:creator>Nikolaj Bøgh</dc:creator><dc:creator>Malene Aastrup</dc:creator><dc:creator>Janne K Mortensen</dc:creator><dc:creator>Hanne Gottrup</dc:creator><dc:creator>Jakob U Blicher</dc:creator><dc:creator>Per Borghammer</dc:creator><dc:creator>Mattias H Kristensen</dc:creator><dc:creator>Esben S S Hansen</dc:creator><dc:creator>Michael Vaeggemose</dc:creator><dc:creator>Christoffer Laustsen</dc:creator><dc:date>2025-04-08</dc:date><dc:identifier>pmid:40197092</dc:identifier><dc:identifier>doi:10.1148/radiol.241808</dc:identifier><dc:source>Radiology</dc:source><dc:title>Comparison of Deuterium Metabolic Imaging with FDG PET in Alzheimer Disease</dc:title></item><item><title>MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)</title><link>https://pubmed.ncbi.nlm.nih.gov/40167440/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background Ductal carcinoma in situ (DCIS) is a nonlethal, preinvasive breast cancer for which breast MRI is best suited for accurate disease extent characterization. DCIS is often overtreated, necessitating robust models for improved risk stratification. Purpose To develop logistic regression models using clinical and MRI-based radiomic features of DCIS and to evaluate the performance of such models in predicting disease upstaging at surgery and DCIS score. Materials and Methods This study is a...]]></description><guid isPermaLink=\"false\">pubmed:40167440</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e241628. doi: 10.1148/radiol.241628.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background Ductal carcinoma in situ (DCIS) is a nonlethal, preinvasive breast cancer for which breast MRI is best suited for accurate disease extent characterization. DCIS is often overtreated, necessitating robust models for improved risk stratification. Purpose To develop logistic regression models using clinical and MRI-based radiomic features of DCIS and to evaluate the performance of such models in predicting disease upstaging at surgery and DCIS score. Materials and Methods This study is a secondary analysis of dynamic contrast-enhanced (DCE) MRI data from the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network, or ECOG-ACRIN, E4112 trial. Primary analysis focused on predicting disease upstaging (<i>n</i> = 295), and secondary analysis focused on predicting DCIS score (<i>n</i> = 174). Radiologist-drawn lesion segmentations and publicly available Cancer Phenomics Toolkit, or CaPTk, software was used to compute 65 radiomic features. Participants were clustered into groups based on their radiomic features (ie, radiomic phenotypes), and principal component analysis was used to summarize the feature space. Clinical information and qualitative MRI features were available. Associations were tested using χ<sup>2</sup> and likelihood ratio tests. Data were split into training and test sets with a 3:2 ratio, and model performance was assessed on the test set using the area under the receiver operating characteristic curve (AUC). Results Data from 297 female participants with median age of 60 years (IQR, 51-67 years) were analyzed. Two radiomic phenotypes were identified that were associated with disease upstaging (<i>P</i> = .007). For predicting disease upstaging, the top three radiomic principal components combined with clinical and qualitative MRI predictors yielded the highest AUC of 0.77 (95% CI: 0.65, 0.88) among all tested models (<i>P</i> = .007), identifying 25% more true-negative (49 of 93 true-negative findings, 53% specificity) findings, compared with using clinical information alone (23 of 93 true-negative findings, 28% specificity). Radiomic models were not predictive of the DCIS score (<i>P</i> &gt; .05). Conclusion In patients with DCIS, combining radiomic metrics with clinical information improved prediction of disease upstaging but not DCIS score. ClinicalTrials.gov Identifier: NCT02352883 <i>Supplemental material is available for this article.</i> ©RSNA, 2025 See also the editorial by Kim and Woo in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167440/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167440</a> | DOI:<a href=https://doi.org/10.1148/radiol.241628>10.1148/radiol.241628</a></p></div>]]></content:encoded><dc:creator>Kalina P Slavkova</dc:creator><dc:creator>Ruya Kang</dc:creator><dc:creator>Anum S Kazerouni</dc:creator><dc:creator>Debosmita Biswas</dc:creator><dc:creator>Vivian Belenky</dc:creator><dc:creator>Rhea Chitalia</dc:creator><dc:creator>Hannah Horng</dc:creator><dc:creator>Michael Hirano</dc:creator><dc:creator>Jennifer Xiao</dc:creator><dc:creator>Ralph L Corsetti</dc:creator><dc:creator>Sara H Javid</dc:creator><dc:creator>Derrick W Spell</dc:creator><dc:creator>Antonio C Wolff</dc:creator><dc:creator>Joseph A Sparano</dc:creator><dc:creator>Seema A Khan</dc:creator><dc:creator>Christopher E Comstock</dc:creator><dc:creator>Justin Romanoff</dc:creator><dc:creator>Constantine Gatsonis</dc:creator><dc:creator>Constance D Lehman</dc:creator><dc:creator>Savannah C Partridge</dc:creator><dc:creator>Jon Steingrimsson</dc:creator><dc:creator>Despina Kontos</dc:creator><dc:creator>Habib Rahbar</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167440</dc:identifier><dc:identifier>doi:10.1148/radiol.241628</dc:identifier><dc:source>Radiology</dc:source><dc:title>MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial)</dc:title></item><item><title>Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease Progression</title><link>https://pubmed.ncbi.nlm.nih.gov/40167439/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health challenge, with evidence indicating that hepatic inflammation and fibrosis are heterogeneous processes. Purpose To measure liver mechanical property heterogeneity using MR elastography (MRE) and evaluate its potential as a biomarker for tissue inflammation and fibrosis in patients with MASLD. Materials and Methods Mechanical tissue heterogeneity in MASLD was assessed at three-dimensional vector...]]></description><guid isPermaLink=\"false\">pubmed:40167439</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e242349. doi: 10.1148/radiol.242349.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health challenge, with evidence indicating that hepatic inflammation and fibrosis are heterogeneous processes. Purpose To measure liver mechanical property heterogeneity using MR elastography (MRE) and evaluate its potential as a biomarker for tissue inflammation and fibrosis in patients with MASLD. Materials and Methods Mechanical tissue heterogeneity in MASLD was assessed at three-dimensional vector MRE pixel-wise histogram analysis of shear stiffness and loss modulus in preclinical and clinical studies. The preclinical study involved 25 rats that were examined monthly, whereas the clinical study analyzed data from 179 participants across two prospective studies (September 2015 to November 2022), including some who underwent bariatric surgery at pretreatment and posttreatment MRE examinations. Mean and coefficient of variation (CV) of shear stiffness and loss modulus were calculated for each examination. Nonparametric tests and Spearman correlation coefficient were used to compare MRE-derived tissue mechanics with biopsy-confirmed fibrosis and inflammation and assess correlations with portal pressure and histopathologic hepatic fibrosis. Results The preclinical study showed that, in cirrhotic livers, CV of loss modulus positively correlated with portal pressure and fibrosis area ratio variation (ρ = 0.52 [<i>P</i> = .008] and 0.55 [<i>P</i> = .005], respectively). The clinical study showed that, in 10 healthy volunteers (median age, 36.5 years; IQR, 34.0-38.8 years; five females) and 169 participants with MASLD (median age, 50.1 years; IQR, 41.0-58.2 years; 118 females), CV of sheer stiffness (from 0.12 to 0.30 in healthy participants to participants with stage 4 fibrosis) and loss modulus (from 0.31 to 0.51 in healthy participants to participants with grade 3 inflammation) increased with increasing severity of fibrosis and inflammation, respectively. In 36 participants who underwent bariatric surgery, the CV of sheer stiffness decreased at the 1-year follow-up, from 0.16 (IQR, 0.14-0.18) to 0.14 (IQR, 0.12-0.16) (<i>P</i> = .009). Conclusion Tissue mechanical heterogeneity assessed at MRE positively correlated with progression of MASLD, demonstrating potential as a biomarker for liver disease severity and therapeutic intervention. ClinicalTrials.gov Identifier: NCT02565446 Published under a CC BY 4.0 license. <i>Supplemental material is available for this article.</i> See also the editorial by Moura Cunha in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167439/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167439</a> | DOI:<a href=https://doi.org/10.1148/radiol.242349>10.1148/radiol.242349</a></p></div>]]></content:encoded><dc:creator>Hao Wu</dc:creator><dc:creator>Zheng Zhu</dc:creator><dc:creator>Jiahui Li</dc:creator><dc:creator>Caixin Qiu</dc:creator><dc:creator>Peng Xu</dc:creator><dc:creator>Kevin J Glaser</dc:creator><dc:creator>Matthew C Murphy</dc:creator><dc:creator>Sudhakar K Venkatesh</dc:creator><dc:creator>Usman Yaqoob</dc:creator><dc:creator>Rondell Graham</dc:creator><dc:creator>Taofic Mounajjed</dc:creator><dc:creator>Armando Manduca</dc:creator><dc:creator>Christopher T Winkelmann</dc:creator><dc:creator>Hiroaki Yashiro</dc:creator><dc:creator>Rohan Manohar</dc:creator><dc:creator>Alina M Allen</dc:creator><dc:creator>Vijay H Shah</dc:creator><dc:creator>Richard L Ehman</dc:creator><dc:creator>Meng Yin</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167439</dc:identifier><dc:identifier>doi:10.1148/radiol.242349</dc:identifier><dc:source>Radiology</dc:source><dc:title>Three-Dimensional Vector MR Elastography for Evaluating Tissue Mechanical Heterogeneity to Assess Liver Disease Progression</dc:title></item><item><title>Distinct Functional MRI Connectivity Patterns and Cortical Volume Variations Associated with Repetitive Blast Exposure in Special Operations Forces Members</title><link>https://pubmed.ncbi.nlm.nih.gov/40167438/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background Special operations forces members often face multiple blast injuries and have a higher risk of traumatic brain injury. However, the relationship between neuroimaging markers, the cumulative severity of injury, and long-term symptoms has not previously been well-established in the literature. Purpose To determine the relationship between the frequency of blast injuries, persistent clinical symptoms, and related cortical volumetric and functional connectivity (FC) changes observed at...]]></description><guid isPermaLink=\"false\">pubmed:40167438</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e233264. doi: 10.1148/radiol.233264.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background Special operations forces members often face multiple blast injuries and have a higher risk of traumatic brain injury. However, the relationship between neuroimaging markers, the cumulative severity of injury, and long-term symptoms has not previously been well-established in the literature. Purpose To determine the relationship between the frequency of blast injuries, persistent clinical symptoms, and related cortical volumetric and functional connectivity (FC) changes observed at brain MRI in special operations forces members. Materials and Methods A cohort of 220 service members from a prospective study between January 2021 and May 2023 with a history of repetitive blast exposure underwent psychodiagnostics and a comprehensive neuroimaging evaluation, including structural and resting-state functional MRI (fMRI). Of these, 212 met the inclusion criteria. Participants were split into two datasets for model development and validation, and each dataset was divided into high- and low-exposure groups based on participants' exposure to various explosives. Differences in FC were analyzed using a general linear model, and cortical gray matter volumes were compared using the Mann-Whitney <i>U</i> test. An external age- and sex-matched healthy control group of 212 participants was extracted from the SRPBS Multidisorder MRI Dataset for volumetric analyses. A multiple linear regression model was used to assess correlations between clinical scores and FC, while a logistic regression model was used to predict exposure group from fMRI scans. Results In the 212 participants (mean age, 43.0 years ± 8.6 [SD]; 160 male [99.5%]) divided into groups with low or high blast exposure, the high-exposure group had higher scores for the Neurobehavioral Symptom Inventory (NSI) (<i>t</i> = 3.16, <i>P</i> &lt; .001) and Posttraumatic Stress Disorder Checklist for <i>Diagnostic and Statistical Manual of Mental Disorders</i> (Fifth Edition) (PCL-5) (<i>t</i> = 2.72, <i>P</i> = .01). FC differences were identified in the bilateral superior and inferior lateral occipital cortex (LOC) (<i>P</i> value range, .001-.04), frontal medial cortex (<i>P</i> &lt; .001), left superior frontal gyrus (<i>P</i> &lt; .001), and precuneus (<i>P</i> value range, .02-.03). Clinical scores from NSI and PCL-5 were inversely correlated with FC in the LOC, superior parietal lobule, precuneus, and default mode networks (<i>r</i> = -0.163 to -0.384; <i>P</i> value range, &lt;.001 to .04). The high-exposure group showed increased cortical volume in regions of the LOC compared with healthy controls and the low-exposure group (<i>P</i> value range, .01-.04). The predictive model helped accurately classify participants into high- and low-exposure groups based on fMRI data with 88.00 sensitivity (95% CI: 78.00, 98.00), 67% specificity (95% CI: 53.00, 81.00), and 73% accuracy (95% CI: 60.00, 86.00). Conclusion Repetitive blast exposure leads to distinct alterations in FC and cortical volume, which correlate with neurobehavioral symptoms. The predictive model suggests that even in the absence of observable anatomic changes, FC may indicate blast-related trauma. © RSNA, 2025 <i>Supplemental material is available for this article.</i></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167438/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167438</a> | DOI:<a href=https://doi.org/10.1148/radiol.233264>10.1148/radiol.233264</a></p></div>]]></content:encoded><dc:creator>Andrea Diociasi</dc:creator><dc:creator>Mary A Iaccarino</dc:creator><dc:creator>Scott Sorg</dc:creator><dc:creator>Emily J Lubin</dc:creator><dc:creator>Caroline Wisialowski</dc:creator><dc:creator>Amol Dua</dc:creator><dc:creator>Can Ozan Tan</dc:creator><dc:creator>Rajiv Gupta</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167438</dc:identifier><dc:identifier>doi:10.1148/radiol.233264</dc:identifier><dc:source>Radiology</dc:source><dc:title>Distinct Functional MRI Connectivity Patterns and Cortical Volume Variations Associated with Repetitive Blast Exposure in Special Operations Forces Members</dc:title></item><item><title>The Updated ACR Manual on MR Safety and How It Will Affect Your Practice</title><link>https://pubmed.ncbi.nlm.nih.gov/40167437/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40167437</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e242954. doi: 10.1148/radiol.242954.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167437/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167437</a> | DOI:<a href=https://doi.org/10.1148/radiol.242954>10.1148/radiol.242954</a></p></div>]]></content:encoded><dc:creator>Emanuel Kanal</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167437</dc:identifier><dc:identifier>doi:10.1148/radiol.242954</dc:identifier><dc:source>Radiology</dc:source><dc:title>The Updated ACR Manual on MR Safety and How It Will Affect Your Practice</dc:title></item><item><title>American College of Radiology Manual on MR Safety: 2024 Update and Revisions</title><link>https://pubmed.ncbi.nlm.nih.gov/40167436/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Since the introduction of the American College of Radiology (ACR) MRI safety guidelines in 2002, the indications for use of MRI in clinical care and research have continued to expand. Similarly, MRI technologies have evolved, with multiple field strengths now available for human imaging. While several publications have updated the ACR recommendations since the first guidelines, a single source in a structured format was lacking. Accordingly, the ACR Committee on MR Safety recently updated the...]]></description><guid isPermaLink=\"false\">pubmed:40167436</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e241405. doi: 10.1148/radiol.241405.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Since the introduction of the American College of Radiology (ACR) MRI safety guidelines in 2002, the indications for use of MRI in clinical care and research have continued to expand. Similarly, MRI technologies have evolved, with multiple field strengths now available for human imaging. While several publications have updated the ACR recommendations since the first guidelines, a single source in a structured format was lacking. Accordingly, the ACR Committee on MR Safety recently updated the online ACR Manual on MR Safety that compiles ACR recommendations for safe use of MRI equipment in humans into a single document. This review describes the new structure of the ACR Manual on MR Safety, discusses new content, indicates gaps in knowledge that require further research, and explains the rationale for the Committee on MR Safety recommendations on certain topics, such as remote operation of MRI systems.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167436/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167436</a> | DOI:<a href=https://doi.org/10.1148/radiol.241405>10.1148/radiol.241405</a></p></div>]]></content:encoded><dc:creator>Ivan Pedrosa</dc:creator><dc:creator>David A Altman</dc:creator><dc:creator>Jonathan R Dillman</dc:creator><dc:creator>Michael N Hoff</dc:creator><dc:creator>Alexander M McKinney</dc:creator><dc:creator>Scott B Reeder</dc:creator><dc:creator>Jeffrey M Rogg</dc:creator><dc:creator>R Jason Stafford</dc:creator><dc:creator>James A Webb</dc:creator><dc:creator>Dina L Hernandez</dc:creator><dc:creator>Robert E Watson</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167436</dc:identifier><dc:identifier>doi:10.1148/radiol.241405</dc:identifier><dc:source>Radiology</dc:source><dc:title>American College of Radiology Manual on MR Safety: 2024 Update and Revisions</dc:title></item><item><title>US Markers for Differentiating Hepatic Inflammation in Chronic Liver Disease: Still a Long Way to Go</title><link>https://pubmed.ncbi.nlm.nih.gov/40167435/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40167435</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e242559. doi: 10.1148/radiol.242559.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167435/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167435</a> | DOI:<a href=https://doi.org/10.1148/radiol.242559>10.1148/radiol.242559</a></p></div>]]></content:encoded><dc:creator>Caixin Qiu</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167435</dc:identifier><dc:identifier>doi:10.1148/radiol.242559</dc:identifier><dc:source>Radiology</dc:source><dc:title>US Markers for Differentiating Hepatic Inflammation in Chronic Liver Disease: Still a Long Way to Go</dc:title></item><item><title>Agenesis of the Intrahepatic Inferior Vena Cava with Pulmonary Venous Fistula</title><link>https://pubmed.ncbi.nlm.nih.gov/40167434/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40167434</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e242069. doi: 10.1148/radiol.242069.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167434/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167434</a> | DOI:<a href=https://doi.org/10.1148/radiol.242069>10.1148/radiol.242069</a></p></div>]]></content:encoded><dc:creator>Xiaoxu Guo</dc:creator><dc:creator>Yuhan Zhou</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167434</dc:identifier><dc:identifier>doi:10.1148/radiol.242069</dc:identifier><dc:source>Radiology</dc:source><dc:title>Agenesis of the Intrahepatic Inferior Vena Cava with Pulmonary Venous Fistula</dc:title></item><item><title>Beyond Proprietary Models: The Potential of Open-Source Large Language Models in Radiology</title><link>https://pubmed.ncbi.nlm.nih.gov/40167433/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40167433</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e242454. doi: 10.1148/radiol.242454.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167433/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167433</a> | DOI:<a href=https://doi.org/10.1148/radiol.242454>10.1148/radiol.242454</a></p></div>]]></content:encoded><dc:creator>Satvik Tripathi</dc:creator><dc:creator>Ali S Tejani</dc:creator><dc:creator>Tessa S Cook</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167433</dc:identifier><dc:identifier>doi:10.1148/radiol.242454</dc:identifier><dc:source>Radiology</dc:source><dc:title>Beyond Proprietary Models: The Potential of Open-Source Large Language Models in Radiology</dc:title></item><item><title>Accuracy of Large Language Model-based Automatic Calculation of Ovarian-Adnexal Reporting and Data System MRI Scores from Pelvic MRI Reports</title><link>https://pubmed.ncbi.nlm.nih.gov/40167432/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background Ovarian-Adnexal Reporting and Data System (O-RADS) for MRI helps assign malignancy risk, but radiologist adoption is inconsistent. Automatic assignment of O-RADS scores from reports could increase adoption and accuracy. Purpose To evaluate the accuracy of large language models (LLMs), after strategic optimization, for automatically calculating O-RADS scores from reports. Materials and Methods This retrospective single-center study from a large quaternary care cancer center included...]]></description><guid isPermaLink=\"false\">pubmed:40167432</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e241554. doi: 10.1148/radiol.241554.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background Ovarian-Adnexal Reporting and Data System (O-RADS) for MRI helps assign malignancy risk, but radiologist adoption is inconsistent. Automatic assignment of O-RADS scores from reports could increase adoption and accuracy. Purpose To evaluate the accuracy of large language models (LLMs), after strategic optimization, for automatically calculating O-RADS scores from reports. Materials and Methods This retrospective single-center study from a large quaternary care cancer center included consecutive gadolinium chelate-enhanced pelvic MRI reports with at least one assigned O-RADS score from July 2021 to October 2023. Reports from January 2018 to October 2019 (before O-RADS MRI implementation) were randomly selected for additional testing. Reference standard O-RADS scores were determined by radiologists interpreting reports. After prompt optimization using a subset of reports, two LLM-based strategies were evaluated: few-shot learning with GPT-4 (version 0613; OpenAI) prompted with O-RADS rules (\"LLM only\") and a hybrid strategy leveraging GPT-4 to classify features fed into a deterministic formula (\"hybrid\"). Accuracy of each model and originally reported scores were calculated and compared using the McNemar test. Results A total of 284 reports from 284 female patients (mean age, 53.2 years ± 16.3 [SD]) with 372 adnexal lesions were included: 10 reports in the training set (16 lesions), 134 reports in the internal test set 1 (173 lesions; 158 O-RADS assigned), and 140 reports in internal test set 2 (183 lesions). For assigning O-RADS MRI scores, the hybrid model accuracy (97%; 168 of 173) outperformed LLM-only model (90%; 155 of 173; <i>P</i> = .006). For lesions with an originally reported O-RADS score, hybrid model accuracy exceeded that of reporting radiologists (97% [153 of 158] vs 88% [139 of 158]; <i>P</i> = .004). Hybrid model also outperformed LLM-only model for 183 lesions from before O-RADS implementation (95% [173 of 183] vs 87% [159 of 183], respectively; <i>P</i> = .01). Conclusion A hybrid LLM-based application, combining LLM feature classification with deterministic elements, accurately assigned O-RADS MRI scores from report descriptions, exceeding both an LLM-only strategy and the original reporting radiologist. © RSNA, 2025 <i>Supplemental material is available for this article.</i></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167432/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167432</a> | DOI:<a href=https://doi.org/10.1148/radiol.241554>10.1148/radiol.241554</a></p></div>]]></content:encoded><dc:creator>Rajesh Bhayana</dc:creator><dc:creator>Ankush Jajodia</dc:creator><dc:creator>Tanya Chawla</dc:creator><dc:creator>Yangqing Deng</dc:creator><dc:creator>Genevieve Bouchard-Fortier</dc:creator><dc:creator>Masoom Haider</dc:creator><dc:creator>Satheesh Krishna</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167432</dc:identifier><dc:identifier>doi:10.1148/radiol.241554</dc:identifier><dc:source>Radiology</dc:source><dc:title>Accuracy of Large Language Model-based Automatic Calculation of Ovarian-Adnexal Reporting and Data System MRI Scores from Pelvic MRI Reports</dc:title></item><item><title>Spatial Viscoelastic Information in Metabolic Dysfunction-associated Steatotic Liver Disease</title><link>https://pubmed.ncbi.nlm.nih.gov/40167431/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40167431</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e250559. doi: 10.1148/radiol.250559.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167431/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167431</a> | DOI:<a href=https://doi.org/10.1148/radiol.250559>10.1148/radiol.250559</a></p></div>]]></content:encoded><dc:creator>Guilherme Moura Cunha</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167431</dc:identifier><dc:identifier>doi:10.1148/radiol.250559</dc:identifier><dc:source>Radiology</dc:source><dc:title>Spatial Viscoelastic Information in Metabolic Dysfunction-associated Steatotic Liver Disease</dc:title></item><item><title>Accuracy of Dual-Energy CT-derived Fat Maps and Bone Marrow Edema Maps in Pedal Osteomyelitis Diagnosis</title><link>https://pubmed.ncbi.nlm.nih.gov/40167430/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[\"Just Accepted\" papers have undergone full peer review and have been accepted for publication in Radiology. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content. Background In patients who cannot undergo MRI, dual-energy CT (DECT) with bone marrow edema (BME) maps are used as an approach for diagnosing pedal...]]></description><guid isPermaLink=\"false\">pubmed:40167430</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e232900. doi: 10.1148/radiol.232900.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\"><i>\"Just Accepted\" papers have undergone full peer review and have been accepted for publication in <i>Radiology</i>. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content.</i> Background In patients who cannot undergo MRI, dual-energy CT (DECT) with bone marrow edema (BME) maps are used as an approach for diagnosing pedal osteomyelitis, but with lower accuracy. Purpose To compare the diagnostic accuracy of additional bone marrow fat maps with that of DECT with BME maps and MRI for pedal osteomyelitis detection. Materials and Methods In this prospective study, thirty-one participants with clinically suspected osteomyelitis of the mid- and forefoot underwent noncontrast DECT (80 kV/140 kV) and MRI between October 2020 and February 2022. With image postprocessing, DECT-derived BME and fat maps were generated. Four independent readers evaluated 3 different image sets for osteomyelitis: DECT and BME maps (set 1); DECT, BME maps and fat maps (set 2); and MRI (set 3). Sensitivity, specificity and accuracy were calculated for each image set, with clinical and microbiological data as the reference standards. In a subanalysis, the DECT BME map, DECT fat map and DECT erosion map were analyzed for their accuracy in predicting bone marrow fat loss at T1-weighted MRI. Results Of the 31 participants included in the study (mean age, 61.7 years ±14.6 [SD]; 21 males) 17 (55%) had osteomyelitis. Sensitivity, specificity and accuracy for detecting osteomyelitis were 47% (8/17), 79% (11/14), and 61% (19/31) (set 1); 77% (13/17), 86% (12/14) and 81% (25/31) (set 2); and 82% (14/17), 93% (13/14) and 87% (27/31) (set 3), respectively. Thirty-one of 661 individual bones (0.5%) showed bone marrow fat loss on T1-weighted MRI; in the subanalysis, DECT fat map specificity was higher than that of the DECT BME map for predicting bone marrow fat loss in individual bones (97% (612/630) vs. 89% (560/630)) (P&lt;.001). Conclusion Pedal osteomyelitis detection with novel DECT-derived fat map imaging in addition to DECT and BME maps was accurate. See also the editorial by Khurana in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167430/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167430</a> | DOI:<a href=https://doi.org/10.1148/radiol.232900>10.1148/radiol.232900</a></p></div>]]></content:encoded><dc:creator>Christoph Stern</dc:creator><dc:creator>Andrea B Rosskopf</dc:creator><dc:creator>Adrian A Marth</dc:creator><dc:creator>Georg C Feuerriegel</dc:creator><dc:creator>Martin C Berli</dc:creator><dc:creator>Benjamin Fritz</dc:creator><dc:creator>Reto Sutter</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167430</dc:identifier><dc:identifier>doi:10.1148/radiol.232900</dc:identifier><dc:source>Radiology</dc:source><dc:title>Accuracy of Dual-Energy CT-derived Fat Maps and Bone Marrow Edema Maps in Pedal Osteomyelitis Diagnosis</dc:title></item><item><title>Dual-Energy CT and Pedal Osteomyelitis</title><link>https://pubmed.ncbi.nlm.nih.gov/40167429/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[\"Just Accepted\" papers have undergone full peer review and have been accepted for publication in Radiology. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content.]]></description><guid isPermaLink=\"false\">pubmed:40167429</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e250212. doi: 10.1148/radiol.250212.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\"><i>\"Just Accepted\" papers have undergone full peer review and have been accepted for publication in <i>Radiology</i>. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content.</i></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167429/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167429</a> | DOI:<a href=https://doi.org/10.1148/radiol.250212>10.1148/radiol.250212</a></p></div>]]></content:encoded><dc:creator>Bharti Khurana</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167429</dc:identifier><dc:identifier>doi:10.1148/radiol.250212</dc:identifier><dc:source>Radiology</dc:source><dc:title>Dual-Energy CT and Pedal Osteomyelitis</dc:title></item><item><title>MRI-based Radiomics for Ductal Carcinoma in Situ: Enhancing Its Role in Risk Stratification</title><link>https://pubmed.ncbi.nlm.nih.gov/40167428/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40167428</guid><pubDate>Tue, 01 Apr 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Apr;315(1):e250085. doi: 10.1148/radiol.250085.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40167428/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40167428</a> | DOI:<a href=https://doi.org/10.1148/radiol.250085>10.1148/radiol.250085</a></p></div>]]></content:encoded><dc:creator>Soo-Yeon Kim</dc:creator><dc:creator>Ok Hee Woo</dc:creator><dc:date>2025-04-01</dc:date><dc:identifier>pmid:40167428</dc:identifier><dc:identifier>doi:10.1148/radiol.250085</dc:identifier><dc:source>Radiology</dc:source><dc:title>MRI-based Radiomics for Ductal Carcinoma in Situ: Enhancing Its Role in Risk Stratification</dc:title></item><item><title>AI in Prostate Cancer Diagnosis with MRI: A Friend Not a Foe</title><link>https://pubmed.ncbi.nlm.nih.gov/40131117/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40131117</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e250525. doi: 10.1148/radiol.250525.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131117/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131117</a> | DOI:<a href=https://doi.org/10.1148/radiol.250525>10.1148/radiol.250525</a></p></div>]]></content:encoded><dc:creator>Carla Harmath</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131117</dc:identifier><dc:identifier>doi:10.1148/radiol.250525</dc:identifier><dc:source>Radiology</dc:source><dc:title>AI in Prostate Cancer Diagnosis with MRI: A Friend Not a Foe</dc:title></item><item><title>US Screening for Liver Lesions in Patients at Risk for HCC: How Well Does LI-RADS US Scoring System Perform?</title><link>https://pubmed.ncbi.nlm.nih.gov/40131116/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40131116</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e250596. doi: 10.1148/radiol.250596.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131116/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131116</a> | DOI:<a href=https://doi.org/10.1148/radiol.250596>10.1148/radiol.250596</a></p></div>]]></content:encoded><dc:creator>Richard G Barr</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131116</dc:identifier><dc:identifier>doi:10.1148/radiol.250596</dc:identifier><dc:source>Radiology</dc:source><dc:title>US Screening for Liver Lesions in Patients at Risk for HCC: How Well Does LI-RADS US Scoring System Perform?</dc:title></item><item><title>Case 339</title><link>https://pubmed.ncbi.nlm.nih.gov/40131115/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[A 66-year-old male patient with a background history of hypertension and no history of liver disease was found to have mildly deranged liver function test results as part of his annual hypertension review. Clinical examination findings were unremarkable, the patient was afebrile (36.8 °C), and other vital observations were within normal limits. Full blood count and urea and creatinine levels were within normal limits; however, liver function tests revealed a mildly elevated alanine...]]></description><guid isPermaLink=\"false\">pubmed:40131115</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e242717. doi: 10.1148/radiol.242717.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">A 66-year-old male patient with a background history of hypertension and no history of liver disease was found to have mildly deranged liver function test results as part of his annual hypertension review. Clinical examination findings were unremarkable, the patient was afebrile (36.8 °C), and other vital observations were within normal limits. Full blood count and urea and creatinine levels were within normal limits; however, liver function tests revealed a mildly elevated alanine aminotransferase level of 61 IU/L (1.02 µkat/L) (reference range, 0-40 IU/L [0-0.67 µkat/L]), and a mildly elevated γ-glutamyltransferase level of 52 IU/L (0.88 µkat/L) (reference range, 0-50 IU/L [0-0.83 µkat/L]). The patient subsequently underwent US examination of the abdomen, which revealed a large liver lesion in an otherwise normal liver with no imaging features of cirrhosis. MRI of the liver was performed for further characterization (Fig 1). The patient subsequently underwent resection of the large mass and surgical pathology. Surveillance MRI was performed 4 months after surgery (Fig 2).</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131115/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131115</a> | DOI:<a href=https://doi.org/10.1148/radiol.242717>10.1148/radiol.242717</a></p></div>]]></content:encoded><dc:creator>Benjamin Rea</dc:creator><dc:creator>Anthony Blakeborough</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131115</dc:identifier><dc:identifier>doi:10.1148/radiol.242717</dc:identifier><dc:source>Radiology</dc:source><dc:title>Case 339</dc:title></item><item><title>LI-RADS for Diagnosing Hepatocellular Carcinoma in Patients with Noncirrhotic Chronic Hepatitis C</title><link>https://pubmed.ncbi.nlm.nih.gov/40131114/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background The Liver Imaging Reporting and Data System (LI-RADS) criteria have not been validated for patients with noncirrhotic chronic hepatitis C (CHC), who are at a greater risk for hepatocellular carcinoma (HCC) than the general population. Purpose To evaluate the diagnostic performance of LI-RADS category 5 (LR-5, indicating definite HCC) observations for HCC using CT and MRI in patients with noncirrhotic CHC and to compare these findings with those in patients with cirrhotic CHC....]]></description><guid isPermaLink=\"false\">pubmed:40131114</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e241856. doi: 10.1148/radiol.241856.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background The Liver Imaging Reporting and Data System (LI-RADS) criteria have not been validated for patients with noncirrhotic chronic hepatitis C (CHC), who are at a greater risk for hepatocellular carcinoma (HCC) than the general population. Purpose To evaluate the diagnostic performance of LI-RADS category 5 (LR-5, indicating definite HCC) observations for HCC using CT and MRI in patients with noncirrhotic CHC and to compare these findings with those in patients with cirrhotic CHC. Materials and Methods This retrospective study included patients without cirrhosis with CHC with focal hepatic nodules of 1 cm or greater on dynamic CT or MRI scans who underwent pathologic confirmation at two university hospitals from August 2002 to February 2022. This group served as the test dataset. The primary outcome was the diagnostic performance of LR-5 for HCC using CT and MRI. When LI-RADS categorization differed between CT and MRI, the MRI-based classification was used as the definitive category. Results were validated using a dataset of patients with CHC from two additional hospitals based on the clinical composite reference standard. Sensitivity, specificity, and area under the receiver operating characteristic curve (AUC) were calculated. Results The test dataset comprised 458 patients (mean age, 64 years ± 9 [SD]; 350 male; 219 without cirrhosis, 239 with cirrhosis). For noncirrhotic livers, the LR-5 criteria achieved an AUC, accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of 0.90 (95% CI: 0.86, 0.93), 85.1% (95% CI: 80.6, 89.7), 82.4% (95% CI: 77.0, 87.8), 97.6% (95% CI: 93.0, 100.0), 99.4% (95% CI: 98.2, 100.0), and 54.7% (95% CI: 43.4, 65.9), respectively. The AUC for LR-5 observations in diagnosing HCC was higher in the noncirrhotic liver group compared with the cirrhotic liver group (AUC, 0.90 [95% CI: 0.86, 0.93] vs 0.79 [95% CI: 0.74, 0.84]; <i>P</i> = .002). The diagnostic performance of the LR-5 criteria for diagnosing HCC was also excellent in patients with noncirrhotic CHC in the validation dataset, which included 155 lesions from 103 patients (mean age, 68 years ± 12; 146 male). The AUC, accuracy, sensitivity, specificity, PPV, and NPV in the validation dataset were 0.91 (95% CI: 0.84, 0.97), 96.1% (95% CI: 93.1, 99.2), 82.9% (95% CI: 70.4, 95.3), 100%, 100%, and 95.2% (95% CI: 91.5, 99.0), respectively. Conclusion The diagnostic performance of LR-5 for HCC in patients with noncirrhotic CHC was comparable to that in patients with cirrhosis across various clinical settings. © RSNA, 2025 <i>Supplemental material is available for this article.</i> See also the editorial by Schöllnast in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131114/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131114</a> | DOI:<a href=https://doi.org/10.1148/radiol.241856>10.1148/radiol.241856</a></p></div>]]></content:encoded><dc:creator>Jihyun An</dc:creator><dc:creator>Rohee Park</dc:creator><dc:creator>Euichang Kim</dc:creator><dc:creator>Seong Kyun Na</dc:creator><dc:creator>Ha Il Kim</dc:creator><dc:creator>In-Hye Song</dc:creator><dc:creator>Young Seo Cho</dc:creator><dc:creator>Ji Hun Kang</dc:creator><dc:creator>Han Chu Lee</dc:creator><dc:creator>Seungbong Han</dc:creator><dc:creator>Jean-Charles Nault</dc:creator><dc:creator>Sang Hyun Choi</dc:creator><dc:creator>Ju Hyun Shim</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131114</dc:identifier><dc:identifier>doi:10.1148/radiol.241856</dc:identifier><dc:source>Radiology</dc:source><dc:title>LI-RADS for Diagnosing Hepatocellular Carcinoma in Patients with Noncirrhotic Chronic Hepatitis C</dc:title></item><item><title>Dysplasia Epiphysealis Hemimelica of Humerus and Glenoid</title><link>https://pubmed.ncbi.nlm.nih.gov/40131113/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40131113</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e241712. doi: 10.1148/radiol.241712.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131113/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131113</a> | DOI:<a href=https://doi.org/10.1148/radiol.241712>10.1148/radiol.241712</a></p></div>]]></content:encoded><dc:creator>Chia-Hui Chen</dc:creator><dc:creator>Chien-Kuo Wang</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131113</dc:identifier><dc:identifier>doi:10.1148/radiol.241712</dc:identifier><dc:source>Radiology</dc:source><dc:title>Dysplasia Epiphysealis Hemimelica of Humerus and Glenoid</dc:title></item><item><title>Case 335: Accidental Intra-Arterial Injection of Contrast Material</title><link>https://pubmed.ncbi.nlm.nih.gov/40131112/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[An 84-year-old female patient presented for routine CT angiography (CTA) of the arteries of the neck following right carotid endarterectomy for 75% stenosis, which had been performed without incident 2 months prior. The patient had also been diagnosed with 72% stenosis of the left carotid artery, although it was asymptomatic and thus endarterectomy was not required. The medical history included arterial hypertension and an incomplete left bundle branch block. CTA was performed according to...]]></description><guid isPermaLink=\"false\">pubmed:40131112</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e241602. doi: 10.1148/radiol.241602.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">An 84-year-old female patient presented for routine CT angiography (CTA) of the arteries of the neck following right carotid endarterectomy for 75% stenosis, which had been performed without incident 2 months prior. The patient had also been diagnosed with 72% stenosis of the left carotid artery, although it was asymptomatic and thus endarterectomy was not required. The medical history included arterial hypertension and an incomplete left bundle branch block. CTA was performed according to standard procedure, with the region of interest to initiate the examination being placed within the aortic arch and contrast material injected at 5 mL/sec via a catheter placed in the left antecubital fossa. The catheter was successfully tested, and the contrast material was subsequently injected without incident, with the patient reporting no pain and the automatic pressure sensor showing no anomalies. The scan was automatically launched because the attenuation within the aortic arch reached 800 HU.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131112/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131112</a> | DOI:<a href=https://doi.org/10.1148/radiol.241602>10.1148/radiol.241602</a></p></div>]]></content:encoded><dc:creator>Thomas Saliba</dc:creator><dc:creator>Olivier Cappeliez</dc:creator><dc:creator>Sanjiva Pather</dc:creator><dc:creator>Henri Maisonnier</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131112</dc:identifier><dc:identifier>doi:10.1148/radiol.241602</dc:identifier><dc:source>Radiology</dc:source><dc:title>Case 335: Accidental Intra-Arterial Injection of Contrast Material</dc:title></item><item><title>Diagnostic Accuracy and Clinical Value of a Domain-specific Multimodal Generative AI Model for Chest Radiograph Report Generation</title><link>https://pubmed.ncbi.nlm.nih.gov/40131111/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background Generative artificial intelligence (AI) is anticipated to alter radiology workflows, requiring a clinical value assessment for frequent examinations like chest radiograph interpretation. Purpose To develop and evaluate the diagnostic accuracy and clinical value of a domain-specific multimodal generative AI model for providing preliminary interpretations of chest radiographs. Materials and Methods For training, consecutive radiograph-report pairs from frontal chest radiography were...]]></description><guid isPermaLink=\"false\">pubmed:40131111</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e241476. doi: 10.1148/radiol.241476.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background Generative artificial intelligence (AI) is anticipated to alter radiology workflows, requiring a clinical value assessment for frequent examinations like chest radiograph interpretation. Purpose To develop and evaluate the diagnostic accuracy and clinical value of a domain-specific multimodal generative AI model for providing preliminary interpretations of chest radiographs. Materials and Methods For training, consecutive radiograph-report pairs from frontal chest radiography were retrospectively collected from 42 hospitals (2005-2023). The trained domain-specific AI model generated radiology reports for the radiographs. The test set included public datasets (PadChest, Open-i, VinDr-CXR, and MIMIC-CXR-JPG) and radiographs excluded from training. The sensitivity and specificity of the model-generated reports for 13 radiographic findings, compared with radiologist annotations (reference standard), were calculated (with 95% CIs). Four radiologists evaluated the subjective quality of the reports in terms of acceptability, agreement score, quality score, and comparative ranking of reports from <i>(a)</i> the domain-specific AI model, <i>(b)</i> radiologists, and <i>(c)</i> a general-purpose large language model (GPT-4Vision). Acceptability was defined as whether the radiologist would endorse the report as their own without changes. Agreement scores from 1 (clinically significant discrepancy) to 5 (complete agreement) were assigned using RADPEER; quality scores were on a 5-point Likert scale from 1 (very poor) to 5 (excellent). Results A total of 8 838 719 radiograph-report pairs (training) and 2145 radiographs (testing) were included (anonymized with respect to sex and gender). Reports generated by the domain-specific AI model demonstrated high sensitivity for detecting two critical radiographic findings: 95.3% (181 of 190) for pneumothorax and 92.6% (138 of 149) for subcutaneous emphysema. Acceptance rate, evaluated by four radiologists, was 70.5% (6047 of 8680), 73.3% (6288 of 8580), and 29.6% (2536 of 8580) for model-generated, radiologist, and GPT-4Vision reports, respectively. Agreement scores were highest for the model-generated reports (median = 4 [IQR, 3-5]) and lowest for GPT-4Vision reports (median = 1 [IQR, 1-3]; <i>P</i> &lt; .001). Quality scores were also highest for the model-generated reports (median = 4 [IQR, 3-5]) and lowest for the GPT-4Vision reports (median = 2 [IQR, 1-3]; <i>P</i> &lt; .001). From the ranking analysis, model-generated reports were most frequently ranked the highest (60.0%; 5146 of 8580), and GPT-4Vision reports were most frequently ranked the lowest (73.6%; 6312 of 8580). Conclusion A domain-specific multimodal generative AI model demonstrated potential for high diagnostic accuracy and clinical value in providing preliminary interpretations of chest radiographs for radiologists. © RSNA, 2025 <i>Supplemental material is available for this article.</i> See also the editorial by Little in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131111/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131111</a> | DOI:<a href=https://doi.org/10.1148/radiol.241476>10.1148/radiol.241476</a></p></div>]]></content:encoded><dc:creator>Eun Kyoung Hong</dc:creator><dc:creator>Jiyeon Ham</dc:creator><dc:creator>Byungseok Roh</dc:creator><dc:creator>Jawook Gu</dc:creator><dc:creator>Beomhee Park</dc:creator><dc:creator>Sunghun Kang</dc:creator><dc:creator>Kihyun You</dc:creator><dc:creator>Jihwan Eom</dc:creator><dc:creator>Byeonguk Bae</dc:creator><dc:creator>Jae-Bock Jo</dc:creator><dc:creator>Ok Kyu Song</dc:creator><dc:creator>Woong Bae</dc:creator><dc:creator>Ro Woon Lee</dc:creator><dc:creator>Chong Hyun Suh</dc:creator><dc:creator>Chan Ho Park</dc:creator><dc:creator>Seong Jun Choi</dc:creator><dc:creator>Jai Soung Park</dc:creator><dc:creator>Jae-Hyeong Park</dc:creator><dc:creator>Hyun Jeong Jeon</dc:creator><dc:creator>Jeong-Ho Hong</dc:creator><dc:creator>Dosang Cho</dc:creator><dc:creator>Han Seok Choi</dc:creator><dc:creator>Tae Hee Kim</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131111</dc:identifier><dc:identifier>doi:10.1148/radiol.241476</dc:identifier><dc:source>Radiology</dc:source><dc:title>Diagnostic Accuracy and Clinical Value of a Domain-specific Multimodal Generative AI Model for Chest Radiograph Report Generation</dc:title></item><item><title>&quot;Fill States&quot;: PET-derived Markers of the Spatial Extent of Alzheimer Disease Pathology</title><link>https://pubmed.ncbi.nlm.nih.gov/40131110/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background Alzheimer disease (AD) progression can be monitored by tracking intensity changes in PET standardized uptake value (SUV) ratios of amyloid, tau, and neurodegeneration. The spatial extent (\"fill state\") of these three hallmark pathologic abnormalities may serve as critical pathophysiologic information, pending further investigation. Purpose To examine the clinical utility and increase the accessibility of PET-derived fill states. Materials and Methods This secondary analysis of two...]]></description><guid isPermaLink=\"false\">pubmed:40131110</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e241482. doi: 10.1148/radiol.241482.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background Alzheimer disease (AD) progression can be monitored by tracking intensity changes in PET standardized uptake value (SUV) ratios of amyloid, tau, and neurodegeneration. The spatial extent (\"fill state\") of these three hallmark pathologic abnormalities may serve as critical pathophysiologic information, pending further investigation. Purpose To examine the clinical utility and increase the accessibility of PET-derived fill states. Materials and Methods This secondary analysis of two prospective studies used data from two independent cohorts: the Alzheimer's Disease Neuroimaging Initiative (ADNI) and the Tau Propagation over Time study (T-POT). Each cohort comprised amyloid-negative cognitively normal individuals (controls) and patients with subjective cognitive decline, mild cognitive impairment, or probable-AD dementia. Fill states of amyloid, tau, and neurodegeneration were computed as the percentages of significantly abnormal voxels relative to controls across PET scans. Fill states and SUV ratios were compared across stages (Kruskal-Wallis <i>H</i> test, area under the receiver operating characteristic curve analysis) and tested for association with the severity of cognitive impairment (Spearman correlation, multivariate regression analysis). Additionally, a convolutional neural network (CNN) was developed to estimate fill states from patients' PET scans without requiring controls. Results The ADNI cohort included 324 individuals (mean age, 72 years ± 6.8 [SD]; 173 [53%] female), and the T-POT cohort comprised 99 individuals (mean age, 66 years ± 8.7; 63 [64%] female). Higher fill states were associated with higher stages of cognitive impairment (<i>P</i> &lt; .001), and tau and neurodegeneration fill states showed higher diagnostic performance for cognitive impairment compared with SUV ratio (<i>P</i> &lt; .05) across cohorts. Similarly, all fill states were negatively correlated with cognitive performance (<i>P</i> &lt; .001) and uniquely characterized the degree of cognitive impairment even after adjustment for SUV ratio (<i>P</i> &lt; .05). The CNN estimated amyloid and tau accurately, but not neurodegeneration fill states. Conclusion Fill states provided reliable markers of AD progression, potentially improving early detection, staging, and monitoring of AD in clinical practice and trials beyond SUV ratio. Clinical trial registration no. NCT00106899 © RSNA, 2025 <i>Supplemental material is available for this article.</i> See also the editorial by Yun and Kim in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131110/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131110</a> | PMC:<a href=\"https://www.ncbi.nlm.nih.gov/pmc/PMC11950890/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">PMC11950890</a> | DOI:<a href=https://doi.org/10.1148/radiol.241482>10.1148/radiol.241482</a></p></div>]]></content:encoded><dc:creator>Elena Doering</dc:creator><dc:creator>Merle C Hoenig</dc:creator><dc:creator>Kathrin Giehl</dc:creator><dc:creator>Verena Dzialas</dc:creator><dc:creator>Grégory Andrassy</dc:creator><dc:creator>Abdelmajid Bader</dc:creator><dc:creator>Andreas Bauer</dc:creator><dc:creator>David Elmenhorst</dc:creator><dc:creator>Johannes Ermert</dc:creator><dc:creator>Silke Frensch</dc:creator><dc:creator>Elena Jäger</dc:creator><dc:creator>Frank Jessen</dc:creator><dc:creator>Philipp Krapf</dc:creator><dc:creator>Tina Kroll</dc:creator><dc:creator>Christoph Lerche</dc:creator><dc:creator>Julia Lothmann</dc:creator><dc:creator>Andreas Matusch</dc:creator><dc:creator>Bernd Neumaier</dc:creator><dc:creator>Oezguer A Onur</dc:creator><dc:creator>Alfredo Ramirez</dc:creator><dc:creator>Nils Richter</dc:creator><dc:creator>Frederik Sand</dc:creator><dc:creator>Lutz Tellmann</dc:creator><dc:creator>Hendrik Theis</dc:creator><dc:creator>Philip Zeyen</dc:creator><dc:creator>Thilo van Eimeren</dc:creator><dc:creator>Alexander Drzezga</dc:creator><dc:creator>Gérard N Bischof</dc:creator><dc:creator>Alzheimer&apos;s Disease Neuroimaging Initiative</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131110</dc:identifier><dc:identifier>pmc:PMC11950890</dc:identifier><dc:identifier>doi:10.1148/radiol.241482</dc:identifier><dc:source>Radiology</dc:source><dc:title>&quot;Fill States&quot;: PET-derived Markers of the Spatial Extent of Alzheimer Disease Pathology</dc:title></item><item><title>Efficacy of Traditional Epidural Patching versus Patching within Spinal Longitudinal Extradural Collections for Ventral Dural Cerebrospinal Fluid Leaks</title><link>https://pubmed.ncbi.nlm.nih.gov/40131109/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background Epidural blood patching is frequently used to treat spontaneous intracranial hypotension (SIH) due to cerebrospinal fluid leaks. However, its effectiveness in sealing ventral dural tears, particularly in chronic cases with organized spinal longitudinal extradural collections (SLECs), is not well documented. Purpose To assess the efficacy of intra-SLEC patching compared with traditional patching for treatment of ventral dural tears. Materials and Methods This two-site retrospective...]]></description><guid isPermaLink=\"false\">pubmed:40131109</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e242194. doi: 10.1148/radiol.242194.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background Epidural blood patching is frequently used to treat spontaneous intracranial hypotension (SIH) due to cerebrospinal fluid leaks. However, its effectiveness in sealing ventral dural tears, particularly in chronic cases with organized spinal longitudinal extradural collections (SLECs), is not well documented. Purpose To assess the efficacy of intra-SLEC patching compared with traditional patching for treatment of ventral dural tears. Materials and Methods This two-site retrospective cross-sectional study conducted between January 2019 and July 2024 included patients with SIH due to a ventral dural tear who underwent epidural patching. Organized SLECs, characterized by sharply demarcated, convex edges and confined to the ventral epidural space, were distinguished from unorganized SLECs, which show fluid distribution in both ventral and dorsal spaces. The Fisher exact test was used to compare the complication rate between treatment groups, and the χ<sup>2</sup> test was used to compare the proportion of patients with SLEC resolution between treatment groups. Results Fifty-two patients (mean age, 44.9 years ± 9.5 [SD]; 30 male patients) were included; before treatment, 39 had organized SLECs and 13 had unorganized SLECs. Overall, 25% (13 of 52) of patients had SLEC resolution after treatment. Organized SLECs were less likely to resolve than unorganized SLECs (six of 39 [15%] vs seven of 13 [54%]; <i>P</i> = .02). In patients with organized SLECs, intra-SLEC patching had a higher success rate (33%; five of 15) than traditional patching (4%; one of 24; <i>P</i> = .046). Multivariable analysis showed that intra-SLEC patching (odds ratio, 13.24 [95% CI: 1, 149]; <i>P</i> = .04) and unorganized SLECs (odds ratio, 21.47 [95% CI: 2, 216]; <i>P</i> = .009) were associated with higher odds of SLEC resolution. Conclusion In 25% of patients with SIH, MRI performed after epidural blood patching showed resolution of the SLEC. Intra-SLEC patching was more effective than traditional patching for treating organized SLECs. © RSNA, 2025 See also the editorial by Urbach in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131109/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131109</a> | DOI:<a href=https://doi.org/10.1148/radiol.242194>10.1148/radiol.242194</a></p></div>]]></content:encoded><dc:creator>Andrew L Callen</dc:creator><dc:creator>Samantha L Pisani Petrucci</dc:creator><dc:creator>Peter Lennarson</dc:creator><dc:creator>Mark F Sedrak</dc:creator><dc:creator>Adriana Gutierrez</dc:creator><dc:creator>Mark D Mamlouk</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131109</dc:identifier><dc:identifier>doi:10.1148/radiol.242194</dc:identifier><dc:source>Radiology</dc:source><dc:title>Efficacy of Traditional Epidural Patching versus Patching within Spinal Longitudinal Extradural Collections for Ventral Dural Cerebrospinal Fluid Leaks</dc:title></item><item><title>Imaging-based Hepatocellular Carcinoma Diagnosis: An Extension of LI-RADS to Patients with Noncirrhotic Hepatitis C</title><link>https://pubmed.ncbi.nlm.nih.gov/40131108/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40131108</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e250627. doi: 10.1148/radiol.250627.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131108/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131108</a> | DOI:<a href=https://doi.org/10.1148/radiol.250627>10.1148/radiol.250627</a></p></div>]]></content:encoded><dc:creator>Helmut Schöllnast</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131108</dc:identifier><dc:identifier>doi:10.1148/radiol.250627</dc:identifier><dc:source>Radiology</dc:source><dc:title>Imaging-based Hepatocellular Carcinoma Diagnosis: An Extension of LI-RADS to Patients with Noncirrhotic Hepatitis C</dc:title></item><item><title>Evaluation of Autoimmune Features in Patients with Idiopathic Pulmonary Fibrosis and Pathologic Usual Interstitial Pneumonia: Implications for CT Patterns and Prognosis</title><link>https://pubmed.ncbi.nlm.nih.gov/40131107/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background The clinical, radiologic, and prognostic implications of interstitial pneumonia with autoimmune features (IPAF) in patients with idiopathic interstitial pneumonia and pathologic usual interstitial pneumonia (UIP) have not been fully evaluated. Purpose To compare autoimmune features according to CT patterns for the diagnosis of idiopathic pulmonary fibrosis (IPF) and to assess the diagnostic and prognostic implications of IPAF in patients with IPF-UIP. Materials and Methods This...]]></description><guid isPermaLink=\"false\">pubmed:40131107</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e242292. doi: 10.1148/radiol.242292.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background The clinical, radiologic, and prognostic implications of interstitial pneumonia with autoimmune features (IPAF) in patients with idiopathic interstitial pneumonia and pathologic usual interstitial pneumonia (UIP) have not been fully evaluated. Purpose To compare autoimmune features according to CT patterns for the diagnosis of idiopathic pulmonary fibrosis (IPF) and to assess the diagnostic and prognostic implications of IPAF in patients with IPF-UIP. Materials and Methods This retrospective study included patients with UIP confirmed by surgical lung biopsy between January 2013 and February 2020. Data regarding clinical, radiologic, and pathologic autoimmune features were collected, and patients were diagnosed with IPAF according to current guidelines. CT signs for connective tissue disease (CTD; anterior upper lobe, straightedge, and exuberant honeycombing signs) were also evaluated. Overall survival (OS) was evaluated using Cox proportional hazards models. Results Among 210 patients included (median age, 64 years; IQR, 60-68 years; 158 male patients), 23 (11.0%) had IPAF. Patients with an alternative diagnosis or CT pattern indeterminate for UIP showed a higher prevalence of autoimmune features that were pathologic (38% [33 of 87] vs 20.3% [25 of 123]; <i>P</i> = .005) and serologic (20% [17 of 87] vs 9.8% [12 of 123]; <i>P</i> = .04) and IPAF (4.1% [five of 123] vs 21% [18 of 87]; <i>P</i> &lt; .001) compared with patients with UIP or probable UIP pattern. However, IPAF was not predictive of OS (hazard ratio [HR], 0.81; 95% CI: 0.38, 1.72; <i>P</i> = .58). Lymphoid follicles (HR, 0.59; 95% CI: 0.37, 0.93; <i>P</i> = .02), CT signs for CTD (HR, 0.31; 95% CI: 0.09, 0.99; <i>P</i> = .047), and use of an antifibrotic agent (HR, 0.31; 95% CI: 0.19, 0.51; <i>P</i> &lt; .001) were independently associated with higher OS, and greater extent of fibrosis on CT scans was associated with worse OS (HR, 1.08; 95% CI: 1.05, 1.11; <i>P</i> &lt; .001). Conclusion In patients with IPF-pathologic UIP, serologic and pathologic autoimmune features were associated with indeterminate or alternative CT patterns. Certain histopathologic and radiologic autoimmune features, but not current IPAF criteria, were associated with survival. © RSNA, 2025 <i>Supplemental material is available for this article.</i> See also the editorial by Ackman in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131107/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131107</a> | DOI:<a href=https://doi.org/10.1148/radiol.242292>10.1148/radiol.242292</a></p></div>]]></content:encoded><dc:creator>Sohee Park</dc:creator><dc:creator>Jooae Choe</dc:creator><dc:creator>Ho Cheol Kim</dc:creator><dc:creator>Hye Jeon Hwang</dc:creator><dc:creator>Eun Jin Chae</dc:creator><dc:creator>Joon Beom Seo</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131107</dc:identifier><dc:identifier>doi:10.1148/radiol.242292</dc:identifier><dc:source>Radiology</dc:source><dc:title>Evaluation of Autoimmune Features in Patients with Idiopathic Pulmonary Fibrosis and Pathologic Usual Interstitial Pneumonia: Implications for CT Patterns and Prognosis</dc:title></item><item><title>From SUV Ratio to Fill States: Advancing PET Quantification of Alzheimer Disease through Spatial Extent</title><link>https://pubmed.ncbi.nlm.nih.gov/40131106/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40131106</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e250545. doi: 10.1148/radiol.250545.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131106/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131106</a> | DOI:<a href=https://doi.org/10.1148/radiol.250545>10.1148/radiol.250545</a></p></div>]]></content:encoded><dc:creator>Mijin Yun</dc:creator><dc:creator>Daesung Kim</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131106</dc:identifier><dc:identifier>doi:10.1148/radiol.250545</dc:identifier><dc:source>Radiology</dc:source><dc:title>From SUV Ratio to Fill States: Advancing PET Quantification of Alzheimer Disease through Spatial Extent</dc:title></item><item><title>Patching within Spinal Longitudinal Extradural Collections for Ventral Dural Tears</title><link>https://pubmed.ncbi.nlm.nih.gov/40131105/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40131105</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e250411. doi: 10.1148/radiol.250411.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131105/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131105</a> | DOI:<a href=https://doi.org/10.1148/radiol.250411>10.1148/radiol.250411</a></p></div>]]></content:encoded><dc:creator>Horst Urbach</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131105</dc:identifier><dc:identifier>doi:10.1148/radiol.250411</dc:identifier><dc:source>Radiology</dc:source><dc:title>Patching within Spinal Longitudinal Extradural Collections for Ventral Dural Tears</dc:title></item><item><title>Generative AI Reporting of Chest Radiographs: Promise and Perspectives</title><link>https://pubmed.ncbi.nlm.nih.gov/40131104/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40131104</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e250234. doi: 10.1148/radiol.250234.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131104/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131104</a> | DOI:<a href=https://doi.org/10.1148/radiol.250234>10.1148/radiol.250234</a></p></div>]]></content:encoded><dc:creator>Brent P Little</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131104</dc:identifier><dc:identifier>doi:10.1148/radiol.250234</dc:identifier><dc:source>Radiology</dc:source><dc:title>Generative AI Reporting of Chest Radiographs: Promise and Perspectives</dc:title></item><item><title>Revisiting the Diagnostic Criteria for Interstitial Pneumonia with Autoimmune Features</title><link>https://pubmed.ncbi.nlm.nih.gov/40131103/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40131103</guid><pubDate>Tue, 25 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e250430. doi: 10.1148/radiol.250430.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40131103/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40131103</a> | DOI:<a href=https://doi.org/10.1148/radiol.250430>10.1148/radiol.250430</a></p></div>]]></content:encoded><dc:creator>Jeanne B Ackman</dc:creator><dc:date>2025-03-25</dc:date><dc:identifier>pmid:40131103</dc:identifier><dc:identifier>doi:10.1148/radiol.250430</dc:identifier><dc:source>Radiology</dc:source><dc:title>Revisiting the Diagnostic Criteria for Interstitial Pneumonia with Autoimmune Features</dc:title></item><item><title>In Pursuit of KI-RADS: Toward a Single, Evidence-based Imaging Classification of Renal Masses</title><link>https://pubmed.ncbi.nlm.nih.gov/40100027/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Despite the successful application of Imaging Reporting and Data Systems to improve the radiologic description and management of disease in many organs, one does not yet exist for the kidney. Instead, the radiologic approach to the kidney has focused on the Bosniak classification system, which is based on imaging characteristics for cystic renal masses, and detecting macroscopic fat within solid renal masses. Radiologically, cystic and solid renal masses are categorized and evaluated separately...]]></description><guid isPermaLink=\"false\">pubmed:40100027</guid><pubDate>Tue, 18 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e240308. doi: 10.1148/radiol.240308.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Despite the successful application of Imaging Reporting and Data Systems to improve the radiologic description and management of disease in many organs, one does not yet exist for the kidney. Instead, the radiologic approach to the kidney has focused on the Bosniak classification system, which is based on imaging characteristics for cystic renal masses, and detecting macroscopic fat within solid renal masses. Radiologically, cystic and solid renal masses are categorized and evaluated separately because of historical precedent, differences in appearance at imaging, and differences in biologic behavior. However, the World Health Organization classification of renal neoplasms does not support such separation. Further, the primary goal has been cancer diagnosis. Differentiating benign from malignant masses is important, but data show that many renal cancers, particularly when small, will not cause harm. Therefore, a critical goal of any unifying, single, imaging-based classification of kidney masses (ie, a Kidney Imaging Reporting and Data System) should be predicting the biologic behavior or aggressiveness of suspected kidney cancer. This system could inform the need for treatment or active surveillance and reduce prevalent overdiagnosis and overtreatment. This review describes the rationale for and challenges in creating such a system and the research needed for it to be developed.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40100027/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40100027</a> | PMC:<a href=\"https://www.ncbi.nlm.nih.gov/pmc/PMC11950888/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">PMC11950888</a> | DOI:<a href=https://doi.org/10.1148/radiol.240308>10.1148/radiol.240308</a></p></div>]]></content:encoded><dc:creator>Stuart G Silverman</dc:creator><dc:creator>Ivan Pedrosa</dc:creator><dc:creator>Nicola Schieda</dc:creator><dc:creator>Vitaly Margulis</dc:creator><dc:creator>Payal Kapur</dc:creator><dc:creator>Matthew S Davenport</dc:creator><dc:date>2025-03-18</dc:date><dc:identifier>pmid:40100027</dc:identifier><dc:identifier>pmc:PMC11950888</dc:identifier><dc:identifier>doi:10.1148/radiol.240308</dc:identifier><dc:source>Radiology</dc:source><dc:title>In Pursuit of KI-RADS: Toward a Single, Evidence-based Imaging Classification of Renal Masses</dc:title></item><item><title>Photon-counting CT-derived Quantification of Hepatic Fat Fraction: A Clinical Validation Study</title><link>https://pubmed.ncbi.nlm.nih.gov/40100026/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background Steatosis is a critical health problem, creating a growing need for opportunistic screening. Early detection may allow for effective treatment and prevention of further liver complications. Purpose To evaluate photon-counting CT (PCCT) fat quantification on contrast-enhanced scans and validate the results against fat quantification via histopathologic assessment, controlled attenuation parameter (CAP) from transient elastography, and MRI proton density fat fraction (PDFF). Materials...]]></description><guid isPermaLink=\"false\">pubmed:40100026</guid><pubDate>Tue, 18 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e241677. doi: 10.1148/radiol.241677.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background Steatosis is a critical health problem, creating a growing need for opportunistic screening. Early detection may allow for effective treatment and prevention of further liver complications. Purpose To evaluate photon-counting CT (PCCT) fat quantification on contrast-enhanced scans and validate the results against fat quantification via histopathologic assessment, controlled attenuation parameter (CAP) from transient elastography, and MRI proton density fat fraction (PDFF). Materials and Methods In this prospective, observational clinical study, PCCT-derived fat fraction quantification was assessed in participants with known or suspected liver disease. Participants underwent PCCT between February 2022 and January 2024. Participants also underwent biopsy, US with CAP measurement, or MRI with a PDFF sequence for hepatic fat fraction quantification. Liver fat fraction was measured on virtual noncontrast PCCT images using spectral processing software with a three-material decomposition algorithm for fat, liver tissue, and iodine. Steatosis was graded for each modality. Correlation between PCCT-based steatosis grades and biopsy- and CAP-based grades was assessed with the Spearman correlation coefficient. Agreement between PCCT and MRI PDFF measurements was assessed with the intraclass correlation coefficient. Receiver operating characteristic curve analysis was conducted to determine the optimal PCCT fat fraction threshold for distinguishing between participants with and those without steatosis. Results The study included 178 participants, of whom 27 (mean age, 60.7 years ± 15.2 [SD]; 18 male participants) underwent liver biopsy, 26 (mean age, 60.0 years ± 18.3; 15 male participants) underwent CAP measurement, and 125 (mean age, 61.2 years ± 13.1; 70 male participants) underwent MRI PDFF measurement. There was excellent agreement between PCCT and MRI PDFF assessment of liver fat fraction (intraclass correlation coefficient, 0.91 [95% CI: 0.87, 0.94]). In stratified analysis, the intraclass correlation coefficient was 0.84 (95% CI: 0.63, 0.93) in participants with known fibrosis and 0.92 (95% CI: 0.88, 0.94) in participants without fibrosis. There was moderate correlation of PCCT-based steatosis grade with histologic (ρ = 0.65) and CAP-based (ρ = 0.45) steatosis grade. Based on the Youden index, the PCCT fat fraction threshold that best discriminated between participants with and those without steatosis was 4.8%, with a maximum achievable sensitivity of 81% (38 of 47) and a specificity of 71% (55 of 78). Conclusion PCCT in a standard clinical setting allowed for accurate estimation of liver fat fraction compared with MRI PDFF-based reference standard measurements. © RSNA, 2025 See also the editorial by Kartalis and Grigoriadis in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40100026/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40100026</a> | DOI:<a href=https://doi.org/10.1148/radiol.241677>10.1148/radiol.241677</a></p></div>]]></content:encoded><dc:creator>Tatjana Dell</dc:creator><dc:creator>Narine Mesropyan</dc:creator><dc:creator>Yannik Layer</dc:creator><dc:creator>Verena Tischler</dc:creator><dc:creator>Leonie Weinhold</dc:creator><dc:creator>Johannes Chang</dc:creator><dc:creator>Christian Jansen</dc:creator><dc:creator>Bernhard Schmidt</dc:creator><dc:creator>Markus Jürgens</dc:creator><dc:creator>Alexander Isaak</dc:creator><dc:creator>Patrick Kupczyk</dc:creator><dc:creator>Claus Christian Pieper</dc:creator><dc:creator>Carsten Meyer</dc:creator><dc:creator>Julian Luetkens</dc:creator><dc:creator>Daniel Kuetting</dc:creator><dc:date>2025-03-18</dc:date><dc:identifier>pmid:40100026</dc:identifier><dc:identifier>doi:10.1148/radiol.241677</dc:identifier><dc:source>Radiology</dc:source><dc:title>Photon-counting CT-derived Quantification of Hepatic Fat Fraction: A Clinical Validation Study</dc:title></item><item><title>Radiologists Were Wrong to Mistrust the Machines</title><link>https://pubmed.ncbi.nlm.nih.gov/40100025/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40100025</guid><pubDate>Tue, 18 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e250402. doi: 10.1148/radiol.250402.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40100025/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40100025</a> | DOI:<a href=https://doi.org/10.1148/radiol.250402>10.1148/radiol.250402</a></p></div>]]></content:encoded><dc:creator>Lars J Grimm</dc:creator><dc:date>2025-03-18</dc:date><dc:identifier>pmid:40100025</dc:identifier><dc:identifier>doi:10.1148/radiol.250402</dc:identifier><dc:source>Radiology</dc:source><dc:title>Radiologists Were Wrong to Mistrust the Machines</dc:title></item><item><title>Personalized Platelet Protocols: Progress, Pitfalls, and Potential</title><link>https://pubmed.ncbi.nlm.nih.gov/40100024/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40100024</guid><pubDate>Tue, 18 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e250488. doi: 10.1148/radiol.250488.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40100024/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40100024</a> | DOI:<a href=https://doi.org/10.1148/radiol.250488>10.1148/radiol.250488</a></p></div>]]></content:encoded><dc:creator>David F Kallmes</dc:creator><dc:creator>Dorothea Altschul</dc:creator><dc:date>2025-03-18</dc:date><dc:identifier>pmid:40100024</dc:identifier><dc:identifier>doi:10.1148/radiol.250488</dc:identifier><dc:source>Radiology</dc:source><dc:title>Personalized Platelet Protocols: Progress, Pitfalls, and Potential</dc:title></item><item><title>Editor&apos;s Note 2024: The Year in Review for &lt;em&gt;Radiology&lt;/em&gt;</title><link>https://pubmed.ncbi.nlm.nih.gov/40100023/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40100023</guid><pubDate>Tue, 18 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e250376. doi: 10.1148/radiol.250376.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40100023/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40100023</a> | DOI:<a href=https://doi.org/10.1148/radiol.250376>10.1148/radiol.250376</a></p></div>]]></content:encoded><dc:creator>Linda Moy</dc:creator><dc:date>2025-03-18</dc:date><dc:identifier>pmid:40100023</dc:identifier><dc:identifier>doi:10.1148/radiol.250376</dc:identifier><dc:source>Radiology</dc:source><dc:title>Editor&apos;s Note 2024: The Year in Review for &lt;em&gt;Radiology&lt;/em&gt;</dc:title></item><item><title>Caroli Syndrome</title><link>https://pubmed.ncbi.nlm.nih.gov/40100022/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40100022</guid><pubDate>Tue, 18 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e242864. doi: 10.1148/radiol.242864.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40100022/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40100022</a> | DOI:<a href=https://doi.org/10.1148/radiol.242864>10.1148/radiol.242864</a></p></div>]]></content:encoded><dc:creator>Jun Wang</dc:creator><dc:creator>Xiaohu Li</dc:creator><dc:date>2025-03-18</dc:date><dc:identifier>pmid:40100022</dc:identifier><dc:identifier>doi:10.1148/radiol.242864</dc:identifier><dc:source>Radiology</dc:source><dc:title>Caroli Syndrome</dc:title></item><item><title>Human-AI Interaction in the ScreenTrustCAD Trial: Recall Proportion and Positive Predictive Value Related to Screening Mammograms Flagged by AI CAD versus a Human Reader</title><link>https://pubmed.ncbi.nlm.nih.gov/40100021/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background The ScreenTrustCAD trial was a prospective study that evaluated the cancer detection rates for combinations of artificial intelligence (AI) computer-aided detection (CAD) and two radiologists. The results raised concerns about the tendency of radiologists to agree with AI CAD too much (when AI CAD made an erroneous flagging) or too little (when AI CAD made a correct flagging). Purpose To evaluate differences in recall proportion and positive predictive value (PPV) related to which...]]></description><guid isPermaLink=\"false\">pubmed:40100021</guid><pubDate>Tue, 18 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e242566. doi: 10.1148/radiol.242566.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background The ScreenTrustCAD trial was a prospective study that evaluated the cancer detection rates for combinations of artificial intelligence (AI) computer-aided detection (CAD) and two radiologists. The results raised concerns about the tendency of radiologists to agree with AI CAD too much (when AI CAD made an erroneous flagging) or too little (when AI CAD made a correct flagging). Purpose To evaluate differences in recall proportion and positive predictive value (PPV) related to which reader flagged the mammogram for consensus discussion: AI CAD and/or radiologists. Materials and Methods Participants were enrolled from April 2021 to June 2022, and each examination was interpreted by three independent readers: two radiologists and AI CAD, after which positive findings were forwarded to the consensus discussion. For each combination of readers flagging an examination, the proportion recalled and the PPV were calculated by dividing the number of pathologic evaluation-verified cancers by the number of positive examinations. Results The study included 54 991 women (median age, 55 years [IQR, 46-65 years]), among whom 5489 were flagged for consensus discussion and 1348 were recalled. For examinations flagged by one reader, the proportion recalled after flagging by one radiologist was larger (14.2% [263 of 1858]) compared with flagging by AI CAD (4.6% [86 of 1886]) (<i>P</i> &lt; .001), whereas the PPV of breast cancer was lower (3.4% [nine of 263] vs 22% [19 of 86]) (<i>P</i> &lt; .001). For examinations flagged by two readers, the proportion recalled after flagging by two radiologists was larger (57.2% [360 of 629]) compared with flagging by AI CAD and one radiologist (38.6% [244 of 632]) (<i>P</i> &lt; .001), whereas the PPV was lower (2.5% [nine of 360] vs 25.0% [61 of 244]) (<i>P</i> &lt; .001). For examinations flagged by all three readers, the proportion recalled was 82.6% (400 of 484) and the PPV was 34.2 (137 of 400). Conclusion A larger proportion of participants were recalled after initial flagging by radiologists compared with those flagged by AI CAD, with a lower proportion of cancer. ClinicalTrials.gov Identifier: NCT04778670 © RSNA, 2025 See also the editorial by Grimm in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40100021/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40100021</a> | DOI:<a href=https://doi.org/10.1148/radiol.242566>10.1148/radiol.242566</a></p></div>]]></content:encoded><dc:creator>Karin E Dembrower</dc:creator><dc:creator>Alessio Crippa</dc:creator><dc:creator>Martin Eklund</dc:creator><dc:creator>Fredrik Strand</dc:creator><dc:date>2025-03-18</dc:date><dc:identifier>pmid:40100021</dc:identifier><dc:identifier>doi:10.1148/radiol.242566</dc:identifier><dc:source>Radiology</dc:source><dc:title>Human-AI Interaction in the ScreenTrustCAD Trial: Recall Proportion and Positive Predictive Value Related to Screening Mammograms Flagged by AI CAD versus a Human Reader</dc:title></item><item><title>Guided Antiplatelet Therapy for Stent-Treated Intracranial Aneurysms: A Cluster-Randomized Trial</title><link>https://pubmed.ncbi.nlm.nih.gov/40100020/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Background During neurointerventional treatment of intracranial aneurysms (IAs), poor antiplatelet drug response increases the risk of a cerebral ischemic event (IE). Replacing clopidogrel with ticagrelor may reduce this risk. Purpose To determine whether platelet function test (PFT)-guided antiplatelet therapy reduces incidence of IEs compared with standard dual antiplatelet therapy (SDAT; daily oral aspirin and clopidogrel, 100 mg and 75 mg, respectively) in patients undergoing endovascular...]]></description><guid isPermaLink=\"false\">pubmed:40100020</guid><pubDate>Tue, 18 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e241509. doi: 10.1148/radiol.241509.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Background During neurointerventional treatment of intracranial aneurysms (IAs), poor antiplatelet drug response increases the risk of a cerebral ischemic event (IE). Replacing clopidogrel with ticagrelor may reduce this risk. Purpose To determine whether platelet function test (PFT)-guided antiplatelet therapy reduces incidence of IEs compared with standard dual antiplatelet therapy (SDAT; daily oral aspirin and clopidogrel, 100 mg and 75 mg, respectively) in patients undergoing endovascular intervention for IAs. Materials and Methods In this prospective, multicenter, cluster-randomized trial, 16 neurointerventional teams were randomly allocated to eight test and eight control clusters. Between May and August 2023, test group participants underwent PFT. Test group participants who showed poor antiplatelet response were administered an increased aspirin dose or were switched from clopidogrel to ticagrelor. The control group was administered SDAT. The primary outcome was any cerebral IE within 30 days after the procedure. The exploratory outcomes were any IE within 7 days, modified Rankin Scale score, and all-cause mortality within 30 days. The safety outcome measure was any bleeding event within 30 days. All outcome analyses were performed using generalized linear mixed-effects models. Results A total of 590 participants were included (median age, 58 years; 374 women). IE incidence within 30 days was lower in the test group than in the control group (6.8% [20 of 295] vs 13.2% [39 of 295]; odds ratio [OR], 0.54; 95% CI: 0.31, 0.94; <i>P</i> = .03) and within 7 days (4.1% [12 of 295] vs 10.8% [32 of 295]; OR, 0.48; 95% CI: 0.25, 0.89; <i>P</i> = .02) after undergoing the procedure. There was no evidence of a difference between the test group and the control group in modified Rankin Scale scores (0.33 vs 0.49, respectively; <i>P</i> = .11) or mortality (0.3% [one of 295] vs 2.0% [six of 295], respectively; <i>P</i> = .54). Furthermore, there was no evidence of a between-group difference in bleeding event incidence (24.1% [71 of 295] vs 31.2% [92 of 295]; OR, 0.67; 95% CI: 0.30, 1.5; <i>P</i> = .32). Conclusion PFT-guided antiplatelet therapy was associated with reduced IE incidence. Administration of 60 mg of ticagrelor did not increase bleeding event incidence. Clinicaltrials.gov Identifier: NCT05825391 © RSNA, 2025 <i>Supplemental material is available for this article.</i> See also the editorial by Kallmes and Altschul in this issue.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40100020/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40100020</a> | DOI:<a href=https://doi.org/10.1148/radiol.241509>10.1148/radiol.241509</a></p></div>]]></content:encoded><dc:creator>Yangyang Zhou</dc:creator><dc:creator>Jun Wang</dc:creator><dc:creator>Wenqiang Li</dc:creator><dc:creator>Jian Liu</dc:creator><dc:creator>Anxin Wang</dc:creator><dc:creator>Yisen Zhang</dc:creator><dc:creator>Shiqing Mu</dc:creator><dc:creator>Ruhang Xie</dc:creator><dc:creator>Qichen Peng</dc:creator><dc:creator>Limin Zhang</dc:creator><dc:creator>Bin Luo</dc:creator><dc:creator>Yuanli Zhao</dc:creator><dc:creator>Yang Wang</dc:creator><dc:creator>Ziqing Zhang</dc:creator><dc:creator>Yixin Lin</dc:creator><dc:creator>Pinyuan Zhang</dc:creator><dc:creator>Jiren Zhang</dc:creator><dc:creator>Liang Li</dc:creator><dc:creator>Xiangdong Yin</dc:creator><dc:creator>Fushun Xiao</dc:creator><dc:creator>Yunpeng Lin</dc:creator><dc:creator>Xiaoning Liu</dc:creator><dc:creator>Yang Bian</dc:creator><dc:creator>Simin Wang</dc:creator><dc:creator>Jingwei Li</dc:creator><dc:creator>Xiaoli Zhang</dc:creator><dc:creator>David M Hasan</dc:creator><dc:creator>Timo Krings</dc:creator><dc:creator>Hongqi Zhang</dc:creator><dc:creator>Xinjian Yang</dc:creator><dc:date>2025-03-18</dc:date><dc:identifier>pmid:40100020</dc:identifier><dc:identifier>doi:10.1148/radiol.241509</dc:identifier><dc:source>Radiology</dc:source><dc:title>Guided Antiplatelet Therapy for Stent-Treated Intracranial Aneurysms: A Cluster-Randomized Trial</dc:title></item><item><title>CT-guided Percutaneous Ethanol Sympatholysis for Hyperhidrosis: How I Do It</title><link>https://pubmed.ncbi.nlm.nih.gov/40100019/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[Hyperhidrosis, excessive sweating from the eccrine sweat glands, is caused by overactivity of the sympathetic nerves. Facial, axillary, and/or palmar hyperhidrosis (excessive sweating of the face, armpits, and hands) has a reported prevalence of 1%-1.6%. This condition is initially treated conservatively using a combination of topical and pharmacologic treatments. Surgical sympathectomy or percutaneous sympatholysis are treatment options for severe hyperhidrosis (grade 3 or 4) that does not...]]></description><guid isPermaLink=\"false\">pubmed:40100019</guid><pubDate>Tue, 18 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e241430. doi: 10.1148/radiol.241430.</p><p><b>ABSTRACT</b></p><p xmlns:xlink=\"http://www.w3.org/1999/xlink\" xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:p1=\"http://pubmed.gov/pub-one\">Hyperhidrosis, excessive sweating from the eccrine sweat glands, is caused by overactivity of the sympathetic nerves. Facial, axillary, and/or palmar hyperhidrosis (excessive sweating of the face, armpits, and hands) has a reported prevalence of 1%-1.6%. This condition is initially treated conservatively using a combination of topical and pharmacologic treatments. Surgical sympathectomy or percutaneous sympatholysis are treatment options for severe hyperhidrosis (grade 3 or 4) that does not respond to conservative management. The aim of intervention is to permanently disrupt the sympathetic signal by targeting the thoracic vertebral levels T2, T3, and T4 of the paravertebral ganglia, located on the anterolateral surface of the vertebral body. This review presents the step-by-step technique for CT-guided percutaneous ethanol sympatholysis and discusses patient selection for the procedure, potential complications, and treatment outcomes. Although more than 90% of patients report complete resolution of hyperhidrosis immediately after sympatholysis, as many as 40% report symptom recurrence within 6 months. The probability of remaining hyperhidrosis-free long term (ie, more than 6 months) after CT-guided sympatholysis is 60%. Procedural risks include a 15% risk of compensatory hyperhidrosis elsewhere in the body, 8% risk of Horner syndrome (mostly self-limiting), 5% risk of pneumothorax, and 3% risk of severe intercostal neuralgia due to nontarget ethanol deposition. Despite the risks, this intervention can be life-altering for those with severe disease.</p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40100019/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40100019</a> | DOI:<a href=https://doi.org/10.1148/radiol.241430>10.1148/radiol.241430</a></p></div>]]></content:encoded><dc:creator>Christos Georgiades</dc:creator><dc:date>2025-03-18</dc:date><dc:identifier>pmid:40100019</dc:identifier><dc:identifier>doi:10.1148/radiol.241430</dc:identifier><dc:source>Radiology</dc:source><dc:title>CT-guided Percutaneous Ethanol Sympatholysis for Hyperhidrosis: How I Do It</dc:title></item><item><title>O-RADS US Version 2022 Improves Patient Risk Stratification When Compared with O-RADS US Version 2019</title><link>https://pubmed.ncbi.nlm.nih.gov/40100018/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40100018</guid><pubDate>Tue, 18 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e242200. doi: 10.1148/radiol.242200.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40100018/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40100018</a> | PMC:<a href=\"https://www.ncbi.nlm.nih.gov/pmc/PMC11950876/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">PMC11950876</a> | DOI:<a href=https://doi.org/10.1148/radiol.242200>10.1148/radiol.242200</a></p></div>]]></content:encoded><dc:creator>Roni Yoeli-Bik</dc:creator><dc:creator>Jacques S Abramowicz</dc:creator><dc:creator>Kristen Wroblewski</dc:creator><dc:creator>Leonhard Donle</dc:creator><dc:creator>Ryan E Longman</dc:creator><dc:creator>Ernst Lengyel</dc:creator><dc:date>2025-03-18</dc:date><dc:identifier>pmid:40100018</dc:identifier><dc:identifier>pmc:PMC11950876</dc:identifier><dc:identifier>doi:10.1148/radiol.242200</dc:identifier><dc:source>Radiology</dc:source><dc:title>O-RADS US Version 2022 Improves Patient Risk Stratification When Compared with O-RADS US Version 2019</dc:title></item><item><title>Photon-counting CT: The New Kid on the Block for Liver Fat Quantification</title><link>https://pubmed.ncbi.nlm.nih.gov/40100017/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40100017</guid><pubDate>Tue, 18 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e250480. doi: 10.1148/radiol.250480.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40100017/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40100017</a> | DOI:<a href=https://doi.org/10.1148/radiol.250480>10.1148/radiol.250480</a></p></div>]]></content:encoded><dc:creator>Nikolaos Kartalis</dc:creator><dc:creator>Aristeidis Grigoriadis</dc:creator><dc:date>2025-03-18</dc:date><dc:identifier>pmid:40100017</dc:identifier><dc:identifier>doi:10.1148/radiol.250480</dc:identifier><dc:source>Radiology</dc:source><dc:title>Photon-counting CT: The New Kid on the Block for Liver Fat Quantification</dc:title></item><item><title>Harnessing the Power of Generative AI to Enhance Radiologist Efficiency and Accuracy</title><link>https://pubmed.ncbi.nlm.nih.gov/40067112/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40067112</guid><pubDate>Tue, 11 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e250339. doi: 10.1148/radiol.250339.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40067112/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40067112</a> | DOI:<a href=https://doi.org/10.1148/radiol.250339>10.1148/radiol.250339</a></p></div>]]></content:encoded><dc:creator>Paul S Babyn</dc:creator><dc:creator>Scott J Adams</dc:creator><dc:date>2025-03-11</dc:date><dc:identifier>pmid:40067112</dc:identifier><dc:identifier>doi:10.1148/radiol.250339</dc:identifier><dc:source>Radiology</dc:source><dc:title>Harnessing the Power of Generative AI to Enhance Radiologist Efficiency and Accuracy</dc:title></item><item><title>Prostate Cancer Screening: Empirical Clinical Practice for 70 Years</title><link>https://pubmed.ncbi.nlm.nih.gov/40067111/?utm_source=no_user_agent&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=0401260&amp;fc=None&amp;ff=20250409092454&amp;v=2.18.0.post9+e462414</link><description><![CDATA[No abstract]]></description><guid isPermaLink=\"false\">pubmed:40067111</guid><pubDate>Tue, 11 Mar 2025 06:00:00 -0400</pubDate><content:encoded><![CDATA[<div><p style=\"color: #4aa564;\"><b>Radiology</b>. 2025 Mar;314(3):e242184. doi: 10.1148/radiol.242184.</p><p><b>NO ABSTRACT</b></p><p style=\"color: lightgray\">PMID:<a href=\"https://pubmed.ncbi.nlm.nih.gov/40067111/?utm_source=no_user_agent&utm_medium=rss&utm_campaign=journals&utm_content=0401260&ff=20250409092454&v=2.18.0.post9+e462414\">40067111</a> | DOI:<a href=https://doi.org/10.1148/radiol.242184>10.1148/radiol.242184</a></p></div>]]></content:encoded><dc:creator>Takeshi Takahashi</dc:creator><dc:date>2025-03-11</dc:date><dc:identifier>pmid:40067111</dc:identifier><dc:identifier>doi:10.1148/radiol.242184</dc:identifier><dc:source>Radiology</dc:source><dc:title>Prostate Cancer Screening: Empirical Clinical Practice for 70 Years</dc:title></item></channel></rss>"
